Patent Grant
11298058
There are many instances in which it is necessary to position at least a portion of a medical device beneath the epidermis of a patient, e.g., in the subcutaneous layer or elsewhere.
For example, the monitoring of the level of glucose or other analytes, such as lactate or oxygen or the like, in certain individuals is vitally important to their health. The monitoring of glucose is particularly important to individuals with diabetes, as they must determine when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
In this regard, devices have been developed for continuous or automatic monitoring of analytes, such as glucose, in the blood stream or interstitial fluid. Many of these analyte measuring devices are configured so that at least a portion of the devices is positioned below the epidermis, e.g., in a blood vessel or in the subcutaneous tissue of a patient.
These devices, as well as other medical devices, may be positioned manually, e.g., by a user or a healthcare worker, or automatically or semi-automatically with the aid of a sensor positioning device. Regardless of the manner in which the device is inserted beneath the skin, it is important that the device positioning process does not adversely affect the operation of the device. Furthermore, it is important that pain is minimal.
As interest in inserting medical devices, e.g., continuous analyte monitoring devices, beneath the epidermis of a patient continues, there is interest in devices and methods for operably inserting such devices. Of interest are such devices and methods that have minimal impact on device function and which produce minimal pain. Of particular interest are continuous analyte monitoring positioning devices that enable clinically accurate analyte information to be obtained substantially immediately following device positioning in a patient.
Generally, the present invention relates to methods and devices for positioning a medical device at least partially beneath the epidermal layer of skin. In certain embodiments, the present invention relates to the continuous and/or automatic in vivo monitoring of the level of an analyte using an analyte sensor and more specifically devices and methods for operably positioning analyte sensors at least partially beneath the epidermal layer of skin. The subject invention is further described with respect to positioning an analyte sensing device (also referred to herein as a “sensor”, “analyte monitoring device/sensor”, and the like) and analyte sensing systems, where such description is in no way intended to limit the scope of the invention. It is understood that the subject invention is applicable to any medical device in which at least a portion of the device is intended to be positioned beneath the epidermis.
Embodiments of the subject invention include analyte sensor positioning devices and methods that are adapted to provide clinically accurate analyte data (e.g., analyte-related signal) substantially immediately after a sensor has been operably positioned in a patient (e.g., at least a portion of the sensor in the subcutaneous tissue, or elsewhere).
Embodiments of the subject invention include systems in which the period of time after a sensor is positioned in a patient, when a first (or only) sensor calibration is required, is substantially reduced (excluding any factory-set calibration) and/or the number of calibrations (excluding any factory-set calibration) is reduced, e.g., to three or less calibrations, e.g., two or less calibrations, e.g., one calibration or no calibrations.
Also provided are sensor positioning devices and methods that at least minimize, and in many instances eliminate, the occurrence of periods of spurious, low analyte readings, e.g., substantially immediately following sensor positioning, during the night, etc.
Embodiments include devices and methods that modulate the sensor positioning speed, or stated otherwise the rate at which a sensor is delivered to a site in a patient, e.g., using at least two different velocities.
Also provided are positioning devices and methods that operably position a sensor in a site of a patient using an acute angle, relative to the skin.
Embodiments also include sensor positioning devices and methods that employ an anesthetic agent.
Aspects include minimal pain, including substantially pain-free, sensor positioning methods and devices and sensor positioning methods and devices that do not substantially interfere with sensor function.
Also provided are systems and kits.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
Throughout the present application, unless a contrary intention appears, the following terms refer to the indicated characteristics.
A “biological fluid” or “physiological fluid” or “body fluid”, is any body fluid in which an analyte can be measured, for example, blood, interstitial fluid, dermal fluid, sweat, tears, and urine. “Blood” includes whole blood and its cell-free components, such as, plasma and serum.
A “counter electrode” refers to an electrode paired with the working electrode, through which passes a current equal in magnitude and opposite in sign to the current passing through the working electrode. In the context of the invention, the term “counter electrode” is meant to include counter electrodes which also function as reference electrodes (i.e., a counter/reference electrode).
An “electrochemical sensor” is a device configured to detect the presence and/or measure the level of an analyte in a sample via electrochemical oxidation and reduction reactions on the sensor. These reactions are transduced to an electrical signal that can be correlated to an amount, concentration, or level of an analyte in the sample.
“Electrolysis” is the electrooxidation or electroreduction of a compound either directly at an electrode or via one or more electron transfer agents.
A compound is “immobilized” on a surface when it is entrapped on or chemically bound to the surface.
A “non-leachable” or “non-releasable” compound or a compound that is “non-leachably disposed” is meant to define a compound that is affixed on the sensor such that it does not substantially diffuse away from the working surface of the working electrode for the period in which the sensor is used (e.g., the period in which the sensor is implanted in a patient or measuring a sample).
Components are “immobilized” within a sensor, for example, when the components are covalently, ionically, or coordinatively bound to constituents of the sensor and/or are entrapped in a polymeric or sol-gel matrix or membrane which precludes mobility. For example, in certain embodiments an anesthetic agent or precursor thereof may be immobilized within a sensor.
An “electron transfer agent” is a compound that carries electrons between the analyte and the working electrode, either directly, or in cooperation with other electron transfer agents. One example of an electron transfer agent is a redox mediator.
A “working electrode” is an electrode at which the analyte (or a second compound whose level depends on the level of the analyte) is electrooxidized or electroreduced with or without the agency of an electron transfer agent.
A “working surface” is that portion of the working electrode which is coated with or is accessible to the electron transfer agent and configured for exposure to an analyte-containing fluid.
A “sensing layer” is a component of the sensor which includes constituents that facilitate the electrolysis of the analyte. The sensing layer may include constituents such as an electron transfer agent, a catalyst which catalyzes a reaction of the analyte to produce a response at the electrode, or both. In some embodiments of the sensor, the sensing layer is non-leachably disposed in proximity to or on the working electrode.
A “non-corroding” conductive material includes non-metallic materials, such as carbon and conductive polymers.
When one item is indicated as being “remote” from another, this is referenced that the two items are at least in different buildings, and may be at least one mile, ten miles, or at least one hundred miles apart. When different items are indicated as being “local” to each other they are not remote from one another (for example, they can be in the same building or the same room of a building). “Communicating”, “transmitting” and the like, of information reference conveying data representing information as electrical or optical signals over a suitable communication channel (for example, a private or public network, wired, optical fiber, wireless radio or satellite, or otherwise). Any communication or transmission can be between devices which are local or remote from one another. “Forwarding” an item refers to any means of getting that item from one location to the next, whether by physically transporting that item or using other known methods (where that is possible) and includes, at least in the case of data, physically transporting a medium carrying the data or communicating the data over a communication channel (including electrical, optical, or wireless). “Receiving” something means it is obtained by any possible means, such as delivery of a physical item. When information is received it may be obtained as data as a result of a transmission (such as by electrical or optical signals over any communication channel of a type mentioned herein), or it may be obtained as electrical or optical signals from reading some other medium (such as a magnetic, optical, or solid state storage device) carrying the information. However, when information is received from a communication it is received as a result of a transmission of that information from elsewhere (local or remote).
When two items are “associated” with one another they are provided in such a way that it is apparent that one is related to the other such as where one references the other.
Items of data are “linked” to one another in a memory when a same data input (for example, filename or directory name or search term) retrieves those items (in a same file or not) or an input of one or more of the linked items retrieves one or more of the others.
It will also be appreciated that throughout the present application, that words such as “cover”, “base” “front”, “back”, “top”, “upper”, and “lower” are used in a relative sense only.
“May” refers to optionally.
When two or more items (for example, elements or processes) are referenced by an alternative “or”, this indicates that either could be present separately or any combination of them could be present together except where the presence of one necessarily excludes the other or others.
Any recited method can be carried out in the order of events recited or in any other order which is logically possible. Reference to a singular item, includes the possibility that there are plural of the same item present.
Before the present invention is described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges as also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, the preferred methods and materials are now described.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention.
The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.
As summarized above, the present invention is related to analyte sensor positioning devices and methods (the term “positioning” is used herein interchangeably with “delivery”, “insertion”, and the like). The present invention is applicable to an analyte monitoring system using a sensor—at least a portion of which is positionable beneath the skin of the user for the in vivo determination of a concentration of an analyte, such as glucose, lactate, and the like, in a body fluid. The sensor may be, for example, subcutaneously positionable in a patient for the continuous or periodic monitoring of an analyte in a patient's interstitial fluid. This may be used to infer the glucose level in the patient's bloodstream. The sensors of the subject invention also include in vivo analyte sensors insertable into a vein, artery, or other portion of the body containing fluid. A sensor of the subject invention is typically configured for monitoring the level of the analyte over a time period which may range from minutes, hours, days, weeks, or longer. Of interest are analyte sensors, such as glucose sensors, that are capable of providing analyte data for about one hour or more, e.g., about a few hours or more, e.g., about a few days of more, e.g., about three days or more, e.g., about five days or more, e.g., about seven days or more, e.g., about several weeks or months.
Embodiments include positioning devices and systems, and methods that provide clinically accurate analyte data (e.g., relative to a reference) substantially immediately, as shown by any suitable technique known to those of skill in the art, e.g., a Clark Error Grid, Parks Error Grid, Continuous Glucose Error Grid, MARD analysis, and the like. For example, in those embodiments in which the sensor is a continuous sensor and at least a portion of the sensor is adapted to be positioned under the skin of a patient, the sensor is adapted to provide clinically accurate analyte data (e.g., relative to a reference) substantially immediately after the sensor is operably positioned in a patient. In other words, the waiting period from the time a sensor is positioned in a user and the time clinically accurate data may be obtained and used by the user, is greatly reduced relative to prior art devices that require a greater waiting period before accurate analyte data may be obtained and used by a user. By “substantially immediately” is meant from about 0 hours to less than about 5 hours, e.g., from about 0 hours to about 3 hours, e.g., from about 0 hours to less than about 1 hour, e.g., from about 30 minutes or less, where in many embodiments the sensors according to the subject invention are capable of providing clinically accurate analyte data once the sensor has been operatively positioned in the patient.
As noted above, embodiments also include analyte monitoring devices and methods having substantially reduced (including eliminated) periods of time of spurious, low analyte readings, as compared to a control, i.e., the period of time in which clinically accurate analyte data is obtainable is greater, as compared to a control. The subject invention may be employed to minimize or eliminate spurious low analyte readings obtained at any time during sensor use, including a period of time immediately after sensor activation (e.g., positioning of an analyte sensor in or on a patient) and/or anytime thereafter. Accordingly, embodiments include sensors positioning devices and methods that enable sensors to provide clinically accurate analyte data substantially immediately after the sensor has been operably positioned in a patient (e.g., in the subcutaneous tissue, etc.) and/or without substantial interruption due to spurious analyte readings
Embodiments include minimal tissue trauma-producing analyte positioning devices and methods, where embodiments include modulating the rate at which a sensor is delivered to a target site. For example, at least two velocities may be used in the positioning of a sensor, where embodiments include a multiple rate sensor delivery protocol having a first sensor delivery rate, followed by a second sensor delivery rate that is less than the first. Embodiments may include opening the skin with a first velocity, and inserting the sensor through the thus-formed skin opening to a target site (e.g., into the subcutaneous tissue) with a second, minimal tissue trauma-producing velocity, where the second velocity is less than the first velocity. Such may be accomplished automatically or semi-automatically with a sensor positioning device. The positioning device may include a sharp portion and a sensor-carrying portion and may be adapted to provide a skin incision and position a sensor in a patient using variable speeds. It is to be understood that such may be accomplished wholly or at least partially manually.
Certain embodiments include two-stage sensor delivery devices and methods and include devices capable of producing at least first and second velocities. Specific embodiments include devices capable of producing a superficial cut in the skin that is no deeper than the epidermis using a first velocity, and inserting the sensor through the thus-formed cut to a target site using a second velocity that is slower than the first velocity. The speed of the first velocity may be selected to minimize the patient's perception of pain and the speed of the second velocity may be selected to minimize tissue damage at the site of eventual glucose measurements. For example, the high speed of the first velocity (e.g., from about 4 to about 8 m/s in certain embodiments) may minimize the patient's pain while the slower speed of the second velocity (e.g., from about 0.025 to about 0.5 m/s in certain embodiments) may minimize the damage due to the tissue at the site of the eventual glucose sensor measurements. Accordingly, a user contacts the device to a skin surface and actuates the device to cut the skin and insert the sensor through the cut to the target site, using at least two different velocities for the incision forming and sensor delivery operations.
The various velocities employed may differ by any suitable amount. For example, in certain embodiments in which two velocities are employed, the velocities may differ by about 25% to about 95%, e.g., by about 60% to about 90%. Velocity change may be gradual or stepped. The change in velocity may be perceptible to the user or not, where in many embodiments the velocity change is not perceptible by the user. In certain embodiments, the sensor positioning process is automatic in that a user need only activate the device, e.g., actuate a button, lever, contact with a skin surface, or the like, to initiate the sensor positioning process, which process then proceeds to completion without any further user intervention. However, in some embodiments one or more parameters may be controllable by the user, e.g., the timing of velocity change, magnitudes of velocity(ies), etc.
Embodiments of the above-described two-speed sensor insertion minimize tissue damage to the superficial layer of the skin, the stratum corneum and epidermis, as a greater force is required to penetrate these outer layers of the skin, and hence a greater likelihood of tissue damage. By limiting the depth of the incision to the upper layers of the skin, i.e., the stratum corneum and epidermis, minimization of tissue damage at the site of the eventual analyte sensor placement in the subcutaneous adipose tissue layer is achieved.
Furthermore, since in certain embodiments a separate sharp is not employed to penetrate below the outer layer of skin, not only is the tissue damage in the subcutaneous adipose layer minimized by use of the slower speed in the second velocity portion of the insertion, but the physical size and dimension of the wound is greatly reduced by eliminating the use of a separate sharp device penetrating below the outer layer of the skin.
In certain embodiments, the sharp device which disrupts the stratum corneum and epidermis may penetrate from about 0.5 mm to about 1.5 mm below the surface of the skin in certain embodiments. In certain analyte sensing systems, the analyte-sensing chemistry layer on the sensor, by contrast, may be positioned below or deeper than this penetration, e.g., below about 0.5 mm to about 1.5 mm below the surface of the skin. The slow speed of the second velocity portion of the insertion displaces the adipose cells in the subcutaneous adipose tissue layer rather than physically disrupting the cells and effectively coring out a cylinder in which the sensor may be subsequently placed. By contrast, in the present invention, the slow speed of the second velocity portion of the insertion minimizes the volume of tissue which has been removed or even displaced by the sensor insertion. As a result, the sensing portion of the sensor is in immediate proximal contact with the surrounding tissue. In contrast to typical insertion methods in which a cylindrical core of tissue is displaced or removed by a high-speed insertion, in the present invention there is no open volume of tissue in which fluids may accumulate forming edema typical of wound response to trauma of this nature. The absence of or the significant reduction of edema in the present invention associated with the minimization of the perturbed volume of tissue contributes to rapid sensor equilibration with the method of sensor insertion described herein compared with conventional sensor insertion procedures.
Embodiments include making a large wide cut through the epidermis, then a much smaller incision in terms of its cross-sectional dimensions through the dermis and into the underlying subcutaneous adipose tissue layer, where in certain embodiments as much as about a fourfold difference in the cross-sectional area (e.g., 0.48 mm2 for the incision in the epidermis compared to 0.12 mm2 for the incision in the subcutaneous layer).
The subject invention also includes anesthetic agents in sensor positioning. That is, certain embodiments include sensor positioning devices, methods and/or sensors that include an anesthetic agent (“active agent”). The active agent may be any suitable anesthetic agent(s) known or to be discovered. Examples of anesthetic agents include, but are not limited to, lidocaine (with or without epinephrine), prilocaine, bupivacaine, benzocaine, and ropivacaine, marcaine (with or without epinephrine) and the like, and combinations thereof, as well as cold sprays such as ethyl chloride sprays.
The active-agent containing devices may be analyte sensors and/or analyte sensor positioning devices in certain embodiments, and/or may be a structure that is positionable near a skin location site at which site an incision is or will be made and sensor is or will be inserted (a body fluid sampling site). In certain embodiments, the structure may be a sensor positioning device, drug delivery device (e.g., insulin delivery device), etc.
In certain embodiments, an active agent may not be carried by a device, but rather may be otherwise applied at or substantially near the sensor insertion site. Accordingly, embodiments include systems having an active agent delivery unit and an analyte sensor.
Active agent employed in the subject invention may be delivered transdermally, by a topical route, formulated as applicator sticks, solutions, suspensions, emulsions, gels, creams, ointments, pastes, jellies, paints, powders, and aerosols. For example, embodiments may include an active agent in the form of a discrete patch or film or plaster or the like adapted to remain in intimate contact with the epidermis of the recipient for a period of time. For example, such transdermal patches may include a base or matrix layer, e.g., polymeric layer, in which active agent is retained. The base or matrix layer may be operably associated with a support or backing. Active agents suitable for transdermal administration may also be delivered by iontophoresis and may take the form of an optionally buffered aqueous solution that includes the active agent. Suitable formulations may include citrate or bis/tris buffer (pH 6) or ethanol/water and contain a suitable amount of active ingredient.
Active agents may be applied via parenteral administration, such as intravenous (“IV”) administration, intramuscular (“IM”), subcutaneous (“SC” or “SQ”), mucosal. The formulations for such administration may include a solution of the active agent dissolved in a pharmaceutically acceptable carrier. Among the acceptable vehicles and solvents that may be employed, include, but are not limited to, water and Ringer's solution, an isotonic sodium chloride, etc. Active agents may be formulated into preparations for injection by dissolving, suspending or emulsifying them in an aqueous or nonaqueous solvent, such as vegetable or other similar oils, synthetic aliphatic acid glycerides, esters of higher aliphatic acids or propylene glycol; and if desired, with conventional additives such as solubilizers, isotonic agents, suspending agents, emulsifying agents, stabilizers and preservatives. These solutions are sterile and generally free of undesirable matter.
In other embodiments, the active agent may be delivered by the use of liposomes which fuse with the cellular membrane or are endocytosed, i.e., by employing ligands attached to the liposome, or attached directly to the oligonucleotide, that bind to surface membrane protein receptors of the cell resulting in endocytosis. By using liposomes, particularly where the liposome surface carries ligands specific for target cells, or are otherwise preferentially directed to a specific organ, one can focus the delivery of the pharmacological agent into the target cells in vivo. (See, e.g., Al-Muhammed, J. Microencapsul. 13:293-306, 1996; Chonn, Curr. Opin. Biotechnol. 6:698-708, 1995; Ostro, Am. J. Hosp. Pharm. 46:1576-1587, 1989). Methods for preparing liposomal suspensions are known in the art and thus will not be described herein in great detail.
Embodiments may also include administration of active agent using an active agent administration device other than a sensor positioning device and a sensor such as, but not limited to, pumps (implantable or external devices and combinations of both (e.g., certain components may be implantable and others may be external to the body such as controls for the implantable components)), epidural injectors, syringes or other injection apparatus, catheter and/or reservoir operably associated with a catheter, etc. For example, in certain embodiments a device employed to deliver active agent to a subject may be a pump, syringe, catheter or reservoir operably associated with a connecting device such as a catheter, tubing, or the like. Containers suitable for delivery of active agent to an active agent administration device include instruments of containment that may be used to deliver, place, attach, and/or insert the active agent into the delivery device for administration of the active agent to a subject and include, but are not limited to, vials, ampules, tubes, capsules, bottles, syringes and bags. Embodiments may also include administration of active agent via a biodegradable implant active agent delivery device. Such may be accomplished by employing syringes to deposit such a biodegradable delivery device under the skin of a subject. The implants degrade completely, so that removal is not necessary.
Embodiments may include employing an electrode to deliver active agent to a subject. For example, an electrode may be used that has a small port at its tip which is connected to a reservoir or pump containing active agent. The active agent delivery electrode may be implanted using any suitable technique such as surgical cut down, laparoscopy, endoscopy, percutaneous procedure, and the like. In certain embodiments a reservoir or pump may also be implanted in the subject's body. The active agent delivery electrode, or other analogous device, may be controllable such that the amount of active agent delivered, the rate at which the active agent may be delivered, and the time period over which the active agent may be delivered, etc., may be controllable and may be adjusted, e.g., by a user and/or healthcare worker.
Accordingly, embodiments include contacting an analyte determination site with active agent, and determining the concentration of an analyte, where the contacting may be by way of an analyte sensor, analyte sensor positioning device or other structure, transdermal administration, parenteral administration, etc.
In those embodiments in which a sensor positioning device and/or sensor or other device includes active agent, the active agent-containing structure may include or incorporate active agent in any suitable manner. For example, at least a portion of a positioning device and/or sensor, e.g., a body fluid-contacting portion, may include active agent, where in certain embodiments substantially the entire positioning device and/or sensor may include active agent. Active agent may be immobilized on a surface of a positioning device and/or sensor or may be configured to diffuse away from a surface of a positioning device and/or sensor. In certain embodiments, at least the portion of the positioning device that is adapted to provide a skin incision, e.g., a sharp of a sensor positioning device, may include active agent.
In certain embodiments, active agent is a coating on at least a portion of positioning device and/or sensor. In certain embodiments, active agent is incorporated, e.g., embedded, or otherwise integrated into a positioning device and/or sensor.
A positioning device and/or sensor may also have the ability to emit or diffuse active agent at a controllable rate, e.g., may include a controlled release, such as a time release, formulation. For example, a positioning device and/or sensor may include a formulation that is designed to release active agent gradually over time, e.g., over about a period of time commensurate with sensor positioning. A controlled release formulation may employ a polymer or other non-anesthetic agent material to control the release of the active agent. The active agent release rate may be slowed by diffusion through the polymer, or the active agent may be released as the polymer degrades or disintegrates in the body.
The active agent may be added to a positioning device and/or sensor during fabrication thereof and/or may be applied after fabrication. For example, a coating containing active agent thereof may be applied to a positioning device and/or sensor after it has been fabricated.
Active agent may be applied to a positioning device and/or sensor by any of a variety of methods, e.g., by spraying the active agent onto at least a portion of a positioning device and/or sensor or by dipping a positioning device and/or sensor into the active agent, or otherwise immersing or flooding a positioning device and/or sensor with the active agent.
The amount of active agent employed may vary depending on a variety of factors such as the particular active agent used, the particulars of the positioning device and/or sensor, etc. In any event, an effective amount of active agent is used—an amount sufficient to provide the requisite anesthetic result for the desired period of time.
Representative analyte sensors, analyte monitoring systems and sensor positioning devices are now described, where such description is for exemplary purposes only and is in no way intended to limit the scope of the invention.
Analyte Sensors and Sensor Systems
The analyte sensors and analyte monitoring systems of the present invention can be utilized under a variety of conditions. The particular configuration of a sensor and other units used in an analyte monitoring system may depend on the use for which the sensor and system are intended and the conditions under which the sensor and system will operate. As noted above, embodiments include a sensor configured for implantation into a patient or user. The term “implantation” is meant broadly to include wholly implantable sensors and sensors in which only a portion of which is implantable under the skin and a portion of which resides above the skin, e.g., for contact to a transmitter, receiver, transceiver, processor, etc. For example, implantation of the sensor may be made in the arterial or venous systems for direct testing of analyte levels in blood. Alternatively, a sensor may be implanted in the interstitial tissue for determining the analyte level in interstitial fluid. This level may be correlated and/or converted to analyte levels in blood or other fluids. The site and depth of implantation may affect the particular shape, components, and configuration of the sensor. Subcutaneous implantation may be desired, in some cases, to limit the depth of implantation of the sensor. Sensors may also be implanted in other regions of the body to determine analyte levels in other fluids. Examples of suitable sensors for use in the analyte monitoring systems of the invention are described in U.S. Pat. Nos. 6,134,461, 6,175,752, and elsewhere.
An exemplary embodiment of an analyte monitoring system 40 for use with an implantable sensor 42, e.g., for use with a subcutaneously implantable sensor, is illustrated in block diagram form in
The sensor control unit 44 may evaluate the signals from the sensor 42 and/or transmit the signals to one or more optional receiver/display units 46, 48 for evaluation. The sensor control unit 44 and/or the receiver/display units 46, 48 may display or otherwise communicate the current level of the analyte. Furthermore, the sensor control unit 44 and/or the receiver/display units 46, 48 may indicate to the patient, via, for example, an audible, visual, or other sensory-stimulating alarm, when the level of the analyte is at or near a threshold level. In some embodiments, an electrical shock may be delivered to the patient as a warning through one of the electrodes or the optional temperature probe of the sensor. For example, if glucose is monitored then an alarm may be used to alert the patient to a hypoglycemic or hyperglycemic glucose level and/or to impending hypoglycemia or hyperglycemia.
A sensor 42 includes at least one working electrode 58 and a substrate 50, as shown in
The working electrode or electrodes 58 are formed using conductive materials 52. The counter electrode 60 and/or reference electrode 62, as well as other optional portions of the sensor 42, such as a temperature probe 66 (see for example
A sensing layer 64 (see for example
In addition to the electrodes 58, 60, 62 and the sensing layer 64, the sensor 42 may also include optional components such as one or more of the following: a temperature probe 66 (see for example
The substrate 50 may be formed using a variety of non-conducting materials, including, for example, polymeric or plastic materials and ceramic materials. Suitable materials for a particular sensor 42 may be determined, at least in part, based on the desired use of the sensor 42 and properties of the materials.
In addition to considerations regarding flexibility, it is often desirable that a sensor 42 should have a substrate 50 which is non-toxic. Preferably, the substrate 50 is approved by one or more appropriate governmental agencies or private groups for in vivo use. Although the substrate 50 in at least some embodiments has uniform dimensions along the entire length of the sensor 42, in other embodiments, the substrate 50 has a distal end 67 and a proximal end 65 with different widths 53, 55, respectively, as illustrated in
At least one conductive trace 52 may be formed on the substrate for use in constructing a working electrode 58. Typically, the working surface 51 of the working electrode 58 is at least a portion of the conductive trace 52 that is in contact with the analyte-containing fluid (e.g., implanted in the patient). In addition, other conductive traces 52 may be formed on the substrate 50 for use as electrodes (e.g., additional working electrodes, as well as counter, counter/reference, and/or reference electrodes) and other components, such as a temperature probe. The conductive traces 52 may extend most of the distance along a length 57 of the sensor 50, as illustrated in
The conductive traces may be formed using a conductive material 56 such as carbon (e.g., graphite), a conductive polymer, a metal or alloy (e.g., gold or gold alloy), or a metallic compound (e.g., ruthenium dioxide or titanium dioxide), and the like. Conductive traces 52 (and channels 54, if used) may be formed with relatively narrow widths. In embodiments with two or more conductive traces 52 on the same side of the substrate 50, the conductive traces 52 are separated by distances sufficient to prevent conduction between the conductive traces 52. The working electrode 58 and the counter electrode 60 (if a separate reference electrode is used) may be made using a conductive material 56, such as carbon.
The reference electrode 62 and/or counter/reference electrode may be formed using conductive material 56 that is a suitable reference material, for example silver/silver chloride or a non-leachable redox couple bound to a conductive material, for example, a carbon-bound redox couple.
The electrical contact 49 may be made using the same material as the conductive material 56 of the conductive traces 52, or alternatively, may be made from a carbon or other non-metallic material, such as a conducting polymer.
A number of exemplary electrode configurations are described below, however, it will be understood that other configurations may also be used.
Alternatively, one or more of the electrodes may be formed on an opposing side of the substrate 50. In another embodiment, two working electrodes 58 and one counter electrode 60 are formed on one side of the substrate 50 and one reference electrode 62 and two temperature probes 66 are formed on an opposing side of the substrate 50, as illustrated in
Some analytes, such as oxygen, may be directly electrooxidized or electroreduced on the working electrode 58. Other analytes, such as glucose and lactate, require the presence of at least one electron transfer agent and/or at least one catalyst to facilitate the electrooxidation or electroreduction of the analyte. Catalysts may also be used for those analytes, such as oxygen, that can be directly electrooxidized or electroreduced on the working electrode 58. For these analytes, each working electrode 58 has a sensing layer 64 formed proximate to or on a working surface of the working electrode 58. In many embodiments, the sensing layer 64 is formed near or on only a small portion of the working electrode 58, e.g., near a tip of the sensor 42.
The sensing layer 64 includes one or more components designed to facilitate the electrolysis of the analyte. The sensing layer 64 may be formed as a solid composition of the desired components (e.g., an electron transfer agent and/or a catalyst). These components may be non-leachable from the sensor 42 and may be immobilized on the sensor 42. For example, the components may be immobilized on a working electrode 58. Alternatively, the components of the sensing layer 64 may be immobilized within or between one or more membranes or films disposed over the working electrode 58 or the components may be immobilized in a polymeric or sol-gel matrix. Examples of immobilized sensing layers are described in, e.g., U.S. Pat. Nos. 5,262,035; 5,264,104; 5,264,105; 5,320,725; 5,593,852; and 5,665,222; and PCT Patent Application No. US1998/002403 entitled “Electrochemical Analyte Sensors Using Thermostable Soybean Peroxidase” filed on Feb. 11, 1998, published as WO-1998/035053.
Sensors having multiple working electrodes 58a may also be used, e.g., and the signals therefrom may be averaged or measurements generated at these working electrodes 58a may be averaged. In addition, multiple readings at a single working electrode 58a or at multiple working electrodes may be averaged.
In many embodiments, the sensing layer 64 contains one or more electron transfer agents in contact with the conductive material 56 of the working electrode 58, as shown for example in
The sensing layer 64 may also include a catalyst which is capable of catalyzing a reaction of the analyte. The catalyst may also, in some embodiments, act as an electron transfer agent. In another embodiment, two sensing layers 63, 64 are used, as shown in
To electrolyze the analyte, a potential (versus a reference potential) is applied across the working and counter electrodes 58, 60. When a potential is applied between the working electrode 58 and the counter electrode 60, an electrical current will flow.
Those skilled in the art will recognize that there are many different reactions that will achieve the same result; namely the electrolysis of an analyte or a compound whose level depends on the level of the analyte.
A variety of optional items may be included in the sensor. One optional item is a temperature probe 66 (see for example
The sensors of the subject invention are biocompatible. Biocompatibility may be achieved in a number of different manners. For example, an optional biocompatible layer 75 may be formed over at least that portion of the sensor 42 which is inserted into the patient, as shown in
An interferant-eliminating layer (not shown) may be included in the sensor 42. The interferant-eliminating layer may include ionic components, such as Nafion® or the like, incorporated into a polymeric matrix to reduce the permeability of the interferant-eliminating layer to ionic interferants having the same charge as the ionic components.
A mass transport limiting layer 74 may be included with the sensor to act as a diffusion-limiting barrier to reduce the rate of mass transport of the analyte, for example, glucose or lactate, into the region around the working electrodes 58. Exemplary layers that may be used are described for example, in U.S. Pat. No. 6,881,551, and elsewhere.
A sensor of the subject invention may be adapted to be a replaceable component in an in vivo analyte monitor, and particularly in an implantable analyte monitor. As described above, in many embodiments the sensor is capable of operation over a period of days or more, e.g., a period of operation may be at least about one day, e.g., at least about three days, e.g., at least about five days, e.g., at least about one week or more, e.g., one month or more. The sensor may then be removed and replaced with a new sensor.
As described above, sensor positioning devices are provided. Embodiments of the subject positioning devices include low impact, minimal pain-producing devices, where certain embodiments are configured to obtain clinically accurate analyte information substantially immediately after sensor positioning. Device embodiments include variable insertion speed devices. Embodiments of the two stage sensor inserters described herein include single use, disposable, self-contained Sensor Delivery Units (“SDU”) which may be included in a continuous glucose monitoring system.
Referring to
The sensor positioning device 120 may have a variety of cross-sectional shapes, as shown in
The sensor 42 itself may include optional features to facilitate insertion. For example, the sensor 42 may be pointed at the tip 123 to ease insertion, as illustrated in
In operation, a sensor is carried by the positioning device to the target site. For example, the sensor 42 is placed within or next to the sensor positioning device 120 (e.g., may be partially or completely held within the sharp of the device, e.g., in a nested configuration or the like) and then a force is provided against the sensor positioning device 120 and/or sensor 42 to carry the sensor 42 into the skin of the patient. As described above, in certain embodiments various speeds may be used in a given insertion, e.g., a first speed followed by a second speed where the first speed is greater relative to the second speed.
In one embodiment, the force is applied to the sensor 42 to push the sensor into the skin, while the sensor positioning device 120 remains stationary and provides structural support to the sensor 42. Alternatively, the force is applied to the sensor positioning device 120 and optionally to the sensor 42 to push a portion of both the sensor 42 and the sensor positioning device 120 through the skin of the patient and into the subcutaneous tissue. In any event, the forces used may be the same or different, as noted herein. The sensor positioning device 120 is optionally pulled out of the skin and subcutaneous tissue with the sensor 42 remaining in the subcutaneous tissue due to frictional forces between the sensor 42 and the patient's tissue. If the sensor 42 includes the optional barb 125, then this structure may also facilitate the retention of the sensor 42 within the interstitial tissue as the barb catches in the tissue. The force applied to the sensor positioning device 120 and/or the sensor 42 may be applied manually or mechanically. The sensor 42 is reproducibly inserted through the skin of the patient.
In certain embodiments, an insertion gun may be used to insert the sensor. One example of an insertion gun 200 for inserting a sensor 42 is shown in
After the sensor 42 is inserted, the insertion gun 200 may contain a mechanism which pulls the sensor positioning device 120 out of the skin of the patient. Such a mechanism may use a spring, electromagnet, or the like to remove the sensor positioning device 120.
The insertion gun may be reusable. The sensor positioning device 120 is often disposable to avoid the possibility of contamination. Alternatively, the sensor positioning device 120 may be sterilized and reused. In addition, the sensor positioning device 120 and/or the sensor 42 may be coated with an anticlotting agent to prevent fouling of the sensor 42.
In one embodiment, the sensor 42 is injected between about 2 to about 12 mm into the interstitial tissue of the patient for subcutaneous implantation, e.g., the sensor is injected about 3 to about 9 mm, e.g., about 5 to about 7 mm, into the interstitial tissue. Other embodiments of the invention may include sensors implanted in other portions of the patient, including, for example, in an artery, vein, or organ. The depth of implantation varies depending on the desired implantation target. In any event, in certain embodiments the injection is at a speed that differs from the speed employed to create an opening in the skin through which the sensor is injected.
Although the sensor 42 may be inserted anywhere in the body, it is often desirable that the insertion site be positioned so that the on-skin sensor control unit 44 may be concealed. In addition, it is often desirable that the insertion site be at a place on the body with a low density of nerve endings to reduce the pain to the patient. Examples of preferred sites for insertion of the sensor 42 and positioning of the on-skin sensor control unit 44 include the abdomen, thigh, leg, upper arm, and shoulder.
Any suitable angle of insertion may be used. An insertion angle is measured from the plane of the skin (i.e., inserting the sensor perpendicular to the skin would be a 90 degree insertion angle). As noted herein, in certain embodiments an angle less than about 90 degrees is used. The orientation of the two stage or two speed sensor inserter device may be either at normal angle to the skin or at an oblique angle to the skin such as but not limited to about 20, about 25, about 30, about 45 or about 60 degrees with respect to the skin surface itself. In contrast with the sensor used in the case of normal or 90 degree insertion, in instances in which other angles are used, the length of the sensor itself may be adjusted by standard trigonometric relations so that the actual depth of placement remains the same (e.g., remains comparable to that achieved using a 90 degree angle), e.g., in certain embodiments about 5.0 mm below the surface of the skin, i.e. in the midst of the subcutaneous adipose tissue layer.
The use of an angled insertion (i.e. less than about 90 degrees relative to the skin) in the present achieves physical separation of the superficial incision from the position in the tissue at which the sensor will be measuring the analyte of interest. Furthermore, the use of angled insertion may decrease the physical displacement of the sensor itself relative to the subcutaneous adipose tissue layer when physical pressure is applied to the sensor mount and transmitter in the course of a patient's normal daily living. This may be especially important for minimizing the occurrences of spurious low readings during periods of sleep.
The use of an angled insertion in the present invention takes advantage of the stratum corneum's reduced susceptibility to shear disruption or penetration compared with rupture due to direct normal insertion. Less force is required to penetrate the stratum corneum and the epidermis using an angled insertion than an insertion conducted at normal incidence. The latter may be accompanied by greater degrees of damage to the underlying tissue as well as the release of various chemical messengers active in the wound response of the epidermis and dermis.
Embodiments also include devices and methods for determining the thickness of the subcutaneous adipose tissue layer in a given individual at a given anatomical site such as the lower left or right abdominal quadrant or the posterior or lateral upper arm. Such devices and/or algorithms may be integrated with a positioning device or may be separate. For example, in the event that the subcutaneous adipose tissue layer at the desired location for the placement of the sensor is less than or approximately equal to a predetermined amount, e.g., about 5.0 mm, sensor lengths and/or angles which correctly place the active glucose transduction area of the sensor in the middle of the targeted subcutaneous adipose tissue layer may be determined and used.
Sensor positioning devices may involve manual, semi-automatic, or automatic operation, referring to the origin of the force that is used both to insert the sensor and to retract any portion of the sensor positioning device out of the skin of the patient that is not intended to remain inserted during the period of sensor operation. Semi-automatic or automatic operation refers to the incorporation of one or more force-generating methods, e.g., wound springs, compressed gas, electromagnet repulsion of a second magnet, and the like, either in combination with manual force or replacing manual force entirely, for the purpose of inserting the sensor and/or retracting any portion of the sensor positioning device out of the skin of the patient that is not intended to remain inserted during the period of sensor operation.
In certain embodiments, a plunger-type button is used as the actuation mechanism of an insertion gun. The button serves the purpose of releasing a compressed spring that drives the sharp tip of the sensor positioning device into the skin of the patient at a fast speed, consistent with minimizing pain, so as to create a superficial skin incision that is no deeper than the epidermis. The sharp tip of the positioning device may then be retracted out of the skin of the patient, manually or using a mechanism such as a spring, electromagnet, or the like. The continued travel of the actuator button would then also serve the purpose of manually driving the sensor into the skin, through the incision created by the sharp tip of the positioning device, at a velocity less than that used to create the incision.
In certain other embodiments of the device, the insertion gun includes a housing and a carrier. The sensor positioning device is typically mounted on the carrier and the sensor is pre-loaded into the sensor positioning device. The carrier drives the sensor positioning device into the skin of the patient using, for example, a cocked or wound spring, a burst of compressed gas, an electromagnet repelled by a second magnet, and the like, within the insertion gun. The velocity of the carrier may be decreased, after the creation of the superficial skin incision, through mechanical means e.g., viscous dashpots, air damping, friction, the addition of mass to the carrier, or the like. The continued motion of the carrier, for the purpose of inserting the sensor into the incision created by the sharp tip of the positioning device, would then occur at a velocity less than that used to create the incision. The sharp tip of the positioning device may be retracted out of the skin of the patient, either after the creation of the skin incision or after sensor insertion, manually or using a mechanism such as a spring, electromagnet, or the like.
Embodiments include a two stage or two velocity sensor inserter device that includes a base, housing, carrier/introducer/sensor assembly, high speed activation button, drive spring, return spring and manual plunger. These inserters may be provided to users fully assembled and armed with a sensor enclosed inside the introducer.
In use, the first stage of the insertion may begin by activating the device, e.g., by pressing the plunger and activation button, to cause the introducer to be propelled into the skin at a higher rate of speed than the speed that will be used at the second stage. The introducer makes a “shallow puncture”, but does not release the sensor.
The “shallow puncture” depth may be controlled by the height and location of the latch ledge features on the housing, or the type and force (rate) of the drive spring or in other ways such as hard stop, increase of friction, magnets, safety lock, or dial (similar to a lancet device), and the like. The “shallow puncture” or superficial incision may not provide a channel into which the glucose sensor is placed, but rather may provide an opening in the upper layer of the skin only with mechanical strength.
After the “shallow puncture” or superficial incision is made through the stratum corneum and epidermis, the return spring retracts the sharp portion of the introducer out of the skin. The overall (uncompressed) height of the return spring positions the introducer/sensor slightly above the surface of the skin (puncture) for the second stage of the insertion.
When the first stage is activated (releasing the latches of the carrier mechanism), the high speed button comes to rest in a lower position on top of the housing, thereby leaving the plunger in the “up” and ready position. The introducer having made the puncture is now in the “next” position (with the sensor still intact).
The second stage of the insertion may be accomplished manually (e.g., similar to and approximately as slow or slower than injection via syringe) by the user. Pressing down on the plunger causes the introducer/carrier/sensor to move from the “next” position and continue into the shallow puncture until the prescribed sensor insertion depth is reached. The prescribed insertion depth may be controlled by the compressed (solid) height of the return spring or in some other way such as hard stop, adhesive mount, safety lock or other similar restraining or limiting device.
When the prescribed depth is reached, the sensor body may be captured by features on an adhesive mount mounted on the patient's skin and released from the introducer for contact with the transmitter which is connectable to the mount. The insertion is complete when the first phase has provided an opening through the outer layer of the skin and the second phase has resulted in the placement of the sensor at the desired depth in the subcutaneous adipose tissue layer,
The user releases the plunger (e.g., by removing their finger) and the return spring causes the introducer to exit the skin and into the “safe for disposal position”. The SDU may then be detached from the mount and discarded accordingly.
A sensor insertion such as described above may be accomplished with one hand and without the benefit of direct line of sight.
The two stage insertion process may be achieved in one motion, (e.g., by the user pressing the top of the plunger and pushing down until it comes to rest on the top of the housing). However, the user may make a “2 motion-2 stage” insertion (by pressing the plunger, stopping after the high speed button has been activated then pressing the plunger).
Referring back to
Referring again to
Optionally, in an alternate embodiment, the sensor introducer assembly housing 2240 may be configured to be retained coupled to the sensor guide portion 2220 after the actuation of the sensor introducer deployment section 2230, such that the sensor introducer assembly housing 2240 may be configured to substantially entirely house or retain the sensor introducer 2250 to avoid contact with the patient, for example. In such configuration, the sensor introducer deployment section 2230 may be configured to be detachably removed from the sensor introducer assembly housing 2240 and discarded after actuation.
As described in further detail below, when the transmitter unit housing 2510 is coupled to the mounting unit, in one embodiment, the transmitter unit housing 2510 may be configured to couple to the engagement portion 2330 of the sensor to displace the sensor from the first predetermined position to the second predetermined position. In this manner, in one embodiment, the sensor introducer 2250 (
Referring again to the Figures, a temperature detection section 2540 may in one embodiment be provided to the lower surface of the transmitter unit 2510 so as to be in physical contact with the patient's skin when the transmitter unit 2510 is coupled to the mounting unit. In this manner, the transmitter unit 2510 may be configured to monitor the on skin temperature of the patient, for example, in analyzing and processing signals received from the sensor associated with the detected analyte levels.
In the manner described above, in particular embodiments, the analyte sensor deployment includes a two stage insertion process where the first transcutaneous placement is achieved by the sensor introducer 2250 at a substantially high velocity, and thereafter, a second subsequent positioning of the sensor is obtained using the manual force applied upon the transmitter unit 2510 when the transmitter unit 2510 is coupled to the mounting unit. In this manner, in one embodiment, actual or perceived pain or trauma associated with the initial skin puncture to trancutaneously position the sensor through the skin layer of the patient is substantially minimized using a high speed introduction mechanism, while the subsequent final positioning of the sensor is thereafter achieved at a relatively slower speed (for example, using manual force applied upon the transmitter unit 2510).
Referring back to
The sensor 42 and the electronic components within the on-skin sensor control unit 44 are coupled via conductive contacts 80. The one or more working electrodes 58, counter electrode 60 (or counter/reference electrode), optional reference electrode 62, and optional temperature probe 66 are attached to individual conductive contacts 80. The on-skin sensor control unit 44 may optionally contain a support structure 82 to hold, support, and/or guide the sensor 42 into the correct position. In the illustrated embodiment of
Referring back to the Figures, the on-skin sensor control unit 44 may include at least a portion of the electronic components that operate the sensor 42 and the analyte monitoring device system 40. One embodiment of the electronics in the on-skin control unit 44 is illustrated as a block diagram in
The on-skin sensor control unit 44 may optionally contain a transmitter or transceiver 98 for transmitting the sensor signals or processed data from the processing circuit 109 to receiver (or transceiver)/display units 46, 48; a data storage unit 102 for temporarily or permanently storing data from the processing circuit 109; a temperature probe circuit 99 for receiving signals from and operating a temperature probe 66; a reference voltage generator 101 for providing a reference voltage for comparison with sensor-generated signals; and/or a watch dog circuit 103 that monitors the operation of the electronic components in the on-skin sensor control unit 44.
Moreover, the sensor control unit 44 may include a bias control generator 105 to correctly bias analog and digital semiconductor devices, an oscillator 107 to provide a clock signal, and a digital logic and timing component to provide timing signals and logic operations for the digital components of the circuit.
The electronics in the on-skin sensor control unit 44 and the sensor 42, 42′ are operated using a power supply 95. The sensor control unit 44 may also optionally include a temperature probe circuit 99.
The output from the sensor circuit 97 and optional temperature probe circuit is coupled into a measurement circuit 96 that obtains signals from the sensor circuit 97 and optional temperature probe circuit 99 and, at least in some embodiments, provides output data in a form that, for example can be read by digital circuits.
In some embodiments, the data from the processing circuit 109 is analyzed and directed to an alarm system 94 (see
In some embodiments, the data (e.g., a current signal, a converted voltage or frequency signal, or fully or partially analyzed data) from processing circuit 109 is transmitted to one or more receiver/display units 46, 48 using a transmitter 98 in the on-skin sensor control unit 44. The transmitter has an antenna 93, such as a wire or similar conductor, formed in the housing 45.
In addition to a transmitter 98, an optional receiver 110 may be included in the on-skin sensor control unit 44. In some cases, the transmitter 98 is a transceiver, operating as both a transmitter and a receiver. The receiver 110 (and/or receiver display/units 46, 48) may be used to receive calibration data for the sensor 42. The calibration data may be used by the processing circuit 109 to correct signals from the sensor 42. This calibration data may be transmitted by the receiver/display unit 46, 48 or from some other source such as a control unit in a doctor's office.
Calibration data may be obtained in a variety of ways. For instance, the calibration data may simply be factory-determined calibration measurements which can be input into the on-skin sensor control unit 44 using the receiver 110 or may alternatively be stored in a calibration data storage unit within the on-skin sensor control unit 44 itself or elsewhere such as, e.g., receiver display/units 46, 48, (in which case a receiver 110 may not be needed). The calibration data storage unit may be, for example, a readable or readable/writeable memory circuit.
Alternative or additional calibration data may be provided based on tests performed by a doctor or some other professional or by the patient himself. For example, it is common for diabetic individuals to determine their own blood glucose concentration using commercially available testing kits. The result of this test is input into the on-skin sensor control unit 44 (and/or receiver display/units 46, 48) either directly, if an appropriate input device (e.g., a keypad, an optical signal receiver, or a port for connection to a keypad or computer) is incorporated in the on-skin sensor control unit 44, or indirectly by inputting the calibration data into the receiver/display unit 46, 48 and transmitting the calibration data to the on-skin sensor control unit 44.
Other methods of independently determining analyte levels may also be used to obtain calibration data. This type of calibration data may supplant or supplement factory-determined calibration values.
In some embodiments of the invention, calibration data may be required at periodic intervals, for example, about every ten hours, eight hours, about once a day, or about once a week, to confirm that accurate analyte levels are being reported. Calibration may also be required each time a new sensor 42 is implanted or if the sensor exceeds a threshold minimum or maximum value or if the rate of change in the sensor signal exceeds a threshold value. In some cases, it may be necessary to wait a period of time after the implantation of the sensor 42 before calibrating to allow the sensor 42 to achieve equilibrium. In some embodiments, the sensor 42 is calibrated only after it has been inserted. In other embodiments, no calibration of the sensor 42 is needed (e.g., a factory calibration may be sufficient).
Regardless of the type of analyte monitoring system employed, it has been observed that transient, low readings may occur for a period of time. These anomalous low readings may occur during the first hours of use, or anytime thereafter. In certain embodiments, spurious low readings may occur during the night and may be referred to as “night time dropouts”. For example, in the context of an operably positioned continuous monitoring analyte sensor under the skin of a user, such spurious low readings may occur for a period of time following sensor positioning and/or during the first night post-positioning. In many instances, the low readings resolve after a period of time. However, these transient, low readings put constraints on analyte monitoring during the low reading period. Attempts to address this problem vary and include delaying calibration and/or reporting readings to the user until after this period of low readings passes after positioning of the sensor or frequent calibration of the sensor—both of which are inconvenient and neither of which are desirable.
However, as noted above embodiments of the subject invention have at least a minimal period, if at all, of spurious low readings, i.e., a substantially reduced sensor equilibration period, including substantially no equilibration period. In this regard, in those embodiments in which an initial post-positioning calibration is required, such may be performed substantially immediately after sensor positioning. For example, in certain embodiments a calibration protocol may include a first post-positioning calibration at less than about 10 hours after a sensor has been operably positioned, e.g., less than about 5 hours, e.g., less than about 3 hours, e.g., less than about 1 hour, e.g., less than about 0.5 hours. One or more additional calibrations may not be required, or may be performed at suitable times thereafter.
The on-skin sensor control unit 44 may include an optional data storage unit 102 which may be used to hold data (e.g., measurements from the sensor or processed data).
In some embodiments of the invention, the analyte monitoring device 40 includes only an on-skin control unit 44 and a sensor 42.
One or more receiver/display units 46, 48 may be provided with the analyte monitoring device 40 for easy access to the data generated by the sensor 42 and may, in some embodiments, process the signals from the on-skin sensor control unit 44 to determine the concentration or level of analyte in the subcutaneous tissue. The receiver may be a transceiver. Receivers may be palm-sized and/or may be adapted to fit on a belt or within a bag or purse that the patient carries.
The receiver/display units 46, 48, as illustrated in block form at
Data received by the receiver 150 is then sent to an analyzer 152.
The output from the analyzer 152 is typically provided to a display 154. The receiver/display units 46, 48 may also include a number of optional items such as a data storage unit 158 to store data, a transmitter 160 which can be used to transmit data, and an input device 162, such as a keypad or keyboard.
In certain embodiments, the receiver/display unit 46, 48 is integrated with a calibration unit (not shown). For example, the receiver/display unit 46, 48 may, for example, include a conventional blood glucose monitor. Devices may be used including those that operate using, for example, electrochemical and colorimetric blood glucose assays, assays of interstitial or dermal fluid, and/or non-invasive optical assays. When a calibration of the implanted sensor is needed, the patient uses the integrated in vitro monitor to generate a reading. The reading may then, for example, automatically be sent by the transmitter 160 of the receiver/display unit 46, 48 to calibrate the sensor 42.
In certain embodiments, analyte data (processed or not) may be forwarded (such as by communication) to a remote location such as a doctor's office if desired, and received there for further use (such as further processing).
Integration with a Drug Administration System
The subject invention also includes sensors used in sensor-based drug delivery systems. The system may provide a drug to counteract the high or low level of the analyte in response to the signals from one or more sensors. Alternatively, the system may monitor the drug concentration to ensure that the drug remains within a desired therapeutic range. The drug delivery system may include one or more (e.g., two or more) sensors, a sensor positioning device, an on-skin sensor control unit, a receiver/display unit, a data storage and controller module, and a drug administration system. In some cases, the receiver/display unit, data storage and controller module, and drug administration system may be integrated in a single unit. The sensor-based drug delivery system may use data from the one or more sensors to provide necessary input for a control algorithm/mechanism in the data storage and controller module to adjust the administration of drugs. As an example, a glucose sensor could be used to control and adjust the administration of insulin. According to certain embodiments of the subject invention, accurate data from the one or more sensors may be obtained substantially immediately after sensor positioning to provide necessary input for a control algorithm/mechanism in the data storage and controller module to adjust the administration of drugs substantially immediately.
Kits
Finally, kits for use in practicing the subject invention are also provided. The subject kits may include one or more sensors as described herein. Embodiments may also include a sensor and/or a sensor positioning device and/or transmitter and/or receiver and/or anesthetic agent, which may or may not be independent of the sensor and/or sensor positioning device.
In addition to one or more of the above-described components, the subject kits may also include written instructions for using a sensor, e.g., positioning a sensor using a sensor positioning device and/or using a sensor to obtain analyte information. The instructions may be printed on a substrate, such as paper or plastic, etc. As such, the instructions may be present in the kits as a package insert, in the labeling of the container of the kit or components thereof (i.e., associated with the packaging or sub-packaging) etc. In other embodiments, the instructions are present as an electronic storage data file present on a suitable computer readable storage medium, e.g., CD-ROM, diskette, etc. In yet other embodiments, the actual instructions are not present in the kit, but means for obtaining the instructions from a remote source, e.g., via the Internet, are provided. An example of this embodiment is a kit that includes a web address where the instructions can be viewed and/or from which the instructions can be downloaded. As with the instructions, this means for obtaining the instructions is recorded on a suitable substrate.
In many embodiments of the subject kits, the components of the kit are packaged in a kit containment element to make a single, easily handled unit, where the kit containment element, e.g., box or analogous structure, may or may not be an airtight container, e.g., to further preserve the one or more sensors and additional reagents (e.g., control solutions), if present, until use.
Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims and their equivalents be covered thereby.
The present application is a continuation of U.S. patent application Ser. No. 15/789,946 filed Oct. 20, 2017, now U.S. Pat. No. 10,307,091, which is a continuation of U.S. patent application Ser. No. 15/141,819 filed Apr. 28, 2016, now U.S. Pat. No. 9,795,331, which is a continuation of U.S. patent application Ser. No. 14/500,705 filed Sep. 29, 2014, now U.S. Pat. No. 9,332,933, which is a continuation of U.S. patent application Ser. No. 12/571,349 filed Sep. 30, 2009, now U.S. Pat. No. 8,852,101, which is a continuation of U.S. patent application Ser. No. 11/535,983 filed Sep. 28, 2006, now U.S. Pat. No. 7,697,967, entitled “Method and Apparatus for Providing Analyte Sensor Insertion”, which claims priority to U.S. Provisional Application No. 60/754,870 filed on Dec. 28, 2005 entitled “Medical Device Insertion”, the disclosures of each of which are incorporated in their entirety by reference for all purposes.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3123790 | Tyler | Mar 1964 | A |
| 3211001 | Petit | Oct 1965 | A |
| 3260656 | Ross, Jr. | Jul 1966 | A |
| 3581062 | Aston | May 1971 | A |
| 3653841 | Klein | Apr 1972 | A |
| 3719564 | Lilly, Jr. et al. | Mar 1973 | A |
| 3776832 | Oswin et al. | Dec 1973 | A |
| 3837339 | Aisenberg et al. | Sep 1974 | A |
| 3926760 | Allen et al. | Dec 1975 | A |
| 3949388 | Fuller | Apr 1976 | A |
| 3960497 | Acord et al. | Jun 1976 | A |
| 3972320 | Kalman | Aug 1976 | A |
| 3979274 | Newman | Sep 1976 | A |
| 4008717 | Kowarski | Feb 1977 | A |
| 4016866 | Lawton | Apr 1977 | A |
| 4033330 | Willis et al. | Jul 1977 | A |
| 4036749 | Anderson | Jul 1977 | A |
| 4055175 | Clemens et al. | Oct 1977 | A |
| 4059406 | Fleet | Nov 1977 | A |
| 4076596 | Connery et al. | Feb 1978 | A |
| 4098574 | Dappen | Jul 1978 | A |
| 4100048 | Pompei et al. | Jul 1978 | A |
| 4120292 | LeBlanc, Jr. et al. | Oct 1978 | A |
| 4129128 | McFarlane | Dec 1978 | A |
| 4151845 | Clemens | May 1979 | A |
| 4168205 | Danniger et al. | Sep 1979 | A |
| 4172770 | Semersky et al. | Oct 1979 | A |
| 4178916 | McNamara | Dec 1979 | A |
| 4206755 | Klein | Jun 1980 | A |
| 4224125 | Nakamura et al. | Sep 1980 | A |
| 4240438 | Updike et al. | Dec 1980 | A |
| 4245634 | Albisser et al. | Jan 1981 | A |
| 4247297 | Berti et al. | Jan 1981 | A |
| 4294258 | Bernard | Oct 1981 | A |
| 4327725 | Cortese et al. | May 1982 | A |
| 4340458 | Lerner et al. | Jul 1982 | A |
| 4344438 | Schultz | Aug 1982 | A |
| 4349728 | Phillips et al. | Sep 1982 | A |
| 4352960 | Dormer et al. | Oct 1982 | A |
| 4356074 | Johnson | Oct 1982 | A |
| 4365637 | Johnson | Dec 1982 | A |
| 4366033 | Richter et al. | Dec 1982 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4375399 | Havas et al. | Mar 1983 | A |
| 4384586 | Christiansen | May 1983 | A |
| 4390621 | Bauer | Jun 1983 | A |
| 4401122 | Clark, Jr. | Aug 1983 | A |
| 4404066 | Johnson | Sep 1983 | A |
| 4418148 | Oberhardt | Nov 1983 | A |
| 4425920 | Bourland et al. | Jan 1984 | A |
| 4427770 | Chen et al. | Jan 1984 | A |
| 4431004 | Bessman et al. | Feb 1984 | A |
| 4436094 | Cerami | Mar 1984 | A |
| 4440175 | Wilkins | Apr 1984 | A |
| 4441968 | Emmer et al. | Apr 1984 | A |
| 4450842 | Zick et al. | May 1984 | A |
| 4458686 | Clark, Jr. | Jul 1984 | A |
| 4461691 | Frank | Jul 1984 | A |
| 4464170 | Clemens et al. | Aug 1984 | A |
| 4469110 | Slama | Sep 1984 | A |
| 4477314 | Richter et al. | Oct 1984 | A |
| 4478976 | Goertz et al. | Oct 1984 | A |
| 4484987 | Gough | Nov 1984 | A |
| 4494950 | Fischell | Jan 1985 | A |
| 4509531 | Ward | Apr 1985 | A |
| 4522690 | Venkatsetty | Jun 1985 | A |
| 4524114 | Samuels et al. | Jun 1985 | A |
| 4526661 | Steckhan et al. | Jul 1985 | A |
| 4527240 | Kvitash | Jul 1985 | A |
| 4534356 | Papadakis | Aug 1985 | A |
| 4538616 | Rogoff | Sep 1985 | A |
| 4543955 | Schroeppel | Oct 1985 | A |
| 4545382 | Higgins et al. | Oct 1985 | A |
| 4552840 | Riffer | Nov 1985 | A |
| 4560534 | Kung et al. | Dec 1985 | A |
| 4571292 | Liu et al. | Feb 1986 | A |
| 4573994 | Fischell et al. | Mar 1986 | A |
| 4581336 | Malloy et al. | Apr 1986 | A |
| 4595011 | Phillips | Jun 1986 | A |
| 4619754 | Niki et al. | Oct 1986 | A |
| 4619793 | Lee | Oct 1986 | A |
| 4627445 | Garcia et al. | Dec 1986 | A |
| 4627842 | Katz | Dec 1986 | A |
| 4627908 | Miller | Dec 1986 | A |
| 4633878 | Bombardien | Jan 1987 | A |
| 4637403 | Garcia et al. | Jan 1987 | A |
| 4650547 | Gough | Mar 1987 | A |
| 4654197 | Lilja et al. | Mar 1987 | A |
| 4655880 | Liu | Apr 1987 | A |
| 4655885 | Hill et al. | Apr 1987 | A |
| 4671288 | Gough | Jun 1987 | A |
| 4679562 | Luksha | Jul 1987 | A |
| 4680268 | Clark, Jr. | Jul 1987 | A |
| 4682602 | Prohaska | Jul 1987 | A |
| 4684537 | Graetzel et al. | Aug 1987 | A |
| 4685463 | Williams | Aug 1987 | A |
| 4685466 | Rau | Aug 1987 | A |
| 4698057 | Joishy | Oct 1987 | A |
| 4703756 | Gough et al. | Nov 1987 | A |
| 4711245 | Higgins et al. | Dec 1987 | A |
| 4711247 | Fishman | Dec 1987 | A |
| 4717673 | Wrighton et al. | Jan 1988 | A |
| 4721601 | Wrighton et al. | Jan 1988 | A |
| 4721677 | Clark, Jr. | Jan 1988 | A |
| 4726378 | Kaplan | Feb 1988 | A |
| 4726716 | McGuire | Feb 1988 | A |
| 4729672 | Takagi | Mar 1988 | A |
| 4731726 | Allen, III | Mar 1988 | A |
| 4749985 | Corsberg | Jun 1988 | A |
| 4755173 | Konopka | Jul 1988 | A |
| 4757022 | Shults et al. | Jul 1988 | A |
| 4758323 | Davis et al. | Jul 1988 | A |
| 4759371 | Franetzki | Jul 1988 | A |
| 4759828 | Young et al. | Jul 1988 | A |
| 4764416 | Ueyama et al. | Aug 1988 | A |
| 4776944 | Janata et al. | Oct 1988 | A |
| 4777953 | Ash et al. | Oct 1988 | A |
| 4779618 | Mund et al. | Oct 1988 | A |
| 4781683 | Wozniak et al. | Nov 1988 | A |
| 4781798 | Gough | Nov 1988 | A |
| 4784736 | Lonsdale et al. | Nov 1988 | A |
| 4795707 | Niiyama et al. | Jan 1989 | A |
| 4796634 | Huntsman et al. | Jan 1989 | A |
| 4805624 | Yao et al. | Feb 1989 | A |
| 4813424 | Wilkins | Mar 1989 | A |
| 4815469 | Cohen et al. | Mar 1989 | A |
| 4820399 | Senda et al. | Apr 1989 | A |
| 4822337 | Newhouse et al. | Apr 1989 | A |
| 4830959 | McNeil et al. | May 1989 | A |
| 4832797 | Vadgama et al. | May 1989 | A |
| RE32947 | Dormer et al. | Jun 1989 | E |
| 4840893 | Hill et al. | Jun 1989 | A |
| 4847785 | Stephens | Jul 1989 | A |
| 4848351 | Finch | Jul 1989 | A |
| 4854322 | Ash et al. | Aug 1989 | A |
| 4865038 | Rich et al. | Sep 1989 | A |
| 4871351 | Feingold | Oct 1989 | A |
| 4871440 | Nagata et al. | Oct 1989 | A |
| 4874500 | Madou et al. | Oct 1989 | A |
| 4890620 | Gough | Jan 1990 | A |
| 4894137 | Takizawa et al. | Jan 1990 | A |
| 4895147 | Bodicky et al. | Jan 1990 | A |
| 4897162 | Lewandowski et al. | Jan 1990 | A |
| 4897173 | Nankai et al. | Jan 1990 | A |
| 4909908 | Ross et al. | Mar 1990 | A |
| 4911794 | Parce et al. | Mar 1990 | A |
| 4917800 | Lonsdale et al. | Apr 1990 | A |
| 4919141 | Zier et al. | Apr 1990 | A |
| 4919767 | Vadgama et al. | Apr 1990 | A |
| 4921199 | Villaveces | May 1990 | A |
| 4923586 | Katayama et al. | May 1990 | A |
| 4925268 | Iyer et al. | May 1990 | A |
| 4927516 | Yamaguchi et al. | May 1990 | A |
| 4934369 | Maxwell | Jun 1990 | A |
| 4935105 | Churchouse | Jun 1990 | A |
| 4935345 | Guibeau et al. | Jun 1990 | A |
| 4938860 | Wogoman | Jul 1990 | A |
| 4944299 | Silvian | Jul 1990 | A |
| 4950378 | Nagara | Aug 1990 | A |
| 4953552 | DeMarzo | Sep 1990 | A |
| 4954129 | Giuliani et al. | Sep 1990 | A |
| 4969468 | Byers et al. | Nov 1990 | A |
| 4970145 | Bennetto et al. | Nov 1990 | A |
| 4974929 | Curry | Dec 1990 | A |
| 4986271 | Wilkins | Jan 1991 | A |
| 4988341 | Columbus et al. | Jan 1991 | A |
| 4994167 | Shults et al. | Feb 1991 | A |
| 4995402 | Smith et al. | Feb 1991 | A |
| 5000180 | Kuypers et al. | Mar 1991 | A |
| 5002054 | Ash et al. | Mar 1991 | A |
| 5013161 | Zaragoza et al. | May 1991 | A |
| 5019974 | Beckers | May 1991 | A |
| 5035860 | Kleingeld et al. | Jul 1991 | A |
| 5036860 | Leigh et al. | Aug 1991 | A |
| 5047044 | Smith et al. | Sep 1991 | A |
| 5050612 | Matsumura | Sep 1991 | A |
| 5051688 | Murase et al. | Sep 1991 | A |
| 5055171 | Peck | Oct 1991 | A |
| 5058592 | Whisler | Oct 1991 | A |
| 5070535 | Hochmair et al. | Dec 1991 | A |
| 5082550 | Rishpon et al. | Jan 1992 | A |
| 5082786 | Nakamoto | Jan 1992 | A |
| 5089112 | Skotheim et al. | Feb 1992 | A |
| 5095904 | Seligman et al. | Mar 1992 | A |
| 5101814 | Palti | Apr 1992 | A |
| 5106365 | Hernandez | Apr 1992 | A |
| 5108564 | Szuminsky et al. | Apr 1992 | A |
| 5108889 | Smith et al. | Apr 1992 | A |
| 5109850 | Blanco et al. | May 1992 | A |
| 5120420 | Nankai et al. | Jun 1992 | A |
| 5122925 | Inpyn | Jun 1992 | A |
| 5126034 | Carter et al. | Jun 1992 | A |
| 5133856 | Yamaguchi et al. | Jul 1992 | A |
| 5135003 | Souma | Aug 1992 | A |
| 5135004 | Adams et al. | Aug 1992 | A |
| 5140985 | Schroeder et al. | Aug 1992 | A |
| 5141868 | Shanks et al. | Aug 1992 | A |
| 5161532 | Joseph | Nov 1992 | A |
| 5165407 | Wilson et al. | Nov 1992 | A |
| 5174291 | Schoonen et al. | Dec 1992 | A |
| 5190041 | Palti | Mar 1993 | A |
| 5192416 | Wang et al. | Mar 1993 | A |
| 5198367 | Aizawa et al. | Mar 1993 | A |
| 5202261 | Musho et al. | Apr 1993 | A |
| 5204264 | Kaminer et al. | Apr 1993 | A |
| 5205920 | Oyama et al. | Apr 1993 | A |
| 5208154 | Weaver et al. | May 1993 | A |
| 5209229 | Gilli | May 1993 | A |
| 5217595 | Smith et al. | Jun 1993 | A |
| 5229282 | Yoshioka et al. | Jul 1993 | A |
| 5231988 | Wernicke et al. | Aug 1993 | A |
| 5234835 | Nestor et al. | Aug 1993 | A |
| 5238729 | Debe | Aug 1993 | A |
| 5243696 | Carr et al. | Sep 1993 | A |
| 5246867 | Lakowicz et al. | Sep 1993 | A |
| 5250439 | Musho et al. | Oct 1993 | A |
| 5251126 | Kahn et al. | Oct 1993 | A |
| 5262035 | Gregg et al. | Nov 1993 | A |
| 5262305 | Heller et al. | Nov 1993 | A |
| 5264103 | Yoshioka et al. | Nov 1993 | A |
| 5264104 | Gregg et al. | Nov 1993 | A |
| 5264105 | Gregg et al. | Nov 1993 | A |
| 5264106 | McAleer et al. | Nov 1993 | A |
| 5271815 | Wong | Dec 1993 | A |
| 5279294 | Anderson et al. | Jan 1994 | A |
| 5284156 | Schramm et al. | Feb 1994 | A |
| 5285792 | Sjoquist et al. | Feb 1994 | A |
| 5286362 | Hoenes et al. | Feb 1994 | A |
| 5286364 | Yacynych et al. | Feb 1994 | A |
| 5288636 | Pollmann et al. | Feb 1994 | A |
| 5293546 | Tadros et al. | Mar 1994 | A |
| 5293877 | O'Hara et al. | Mar 1994 | A |
| 5299571 | Mastrototaro | Apr 1994 | A |
| 5320098 | Davidson | Jun 1994 | A |
| 5320715 | Berg | Jun 1994 | A |
| 5320725 | Gregg et al. | Jun 1994 | A |
| 5322063 | Allen et al. | Jun 1994 | A |
| 5337747 | Neftei | Aug 1994 | A |
| 5340722 | Wolfbeis et al. | Aug 1994 | A |
| 5342789 | Chick et al. | Aug 1994 | A |
| 5352348 | Young et al. | Oct 1994 | A |
| 5356786 | Heller et al. | Oct 1994 | A |
| 5360404 | Novacek et al. | Nov 1994 | A |
| 5368028 | Palti | Nov 1994 | A |
| 5372133 | Hogen Esch | Dec 1994 | A |
| 5372427 | Padovani et al. | Dec 1994 | A |
| 5376251 | Kaneko et al. | Dec 1994 | A |
| 5378628 | Gratzel et al. | Jan 1995 | A |
| 5379238 | Stark | Jan 1995 | A |
| 5384547 | Lynk et al. | Jan 1995 | A |
| 5387327 | Khan | Feb 1995 | A |
| 5390670 | Centa et al. | Feb 1995 | A |
| 5390671 | Lord et al. | Feb 1995 | A |
| 5391250 | Cheney, II et al. | Feb 1995 | A |
| 5395504 | Saurer et al. | Mar 1995 | A |
| 5400782 | Beaubiah | Mar 1995 | A |
| 5408999 | Singh et al. | Apr 1995 | A |
| 5410326 | Goldstein | Apr 1995 | A |
| 5411647 | Johnson et al. | May 1995 | A |
| 5425361 | Fenzlein et al. | Jun 1995 | A |
| 5431160 | Wilkins | Jul 1995 | A |
| 5431921 | Thombre | Jul 1995 | A |
| 5437999 | Diebold et al. | Aug 1995 | A |
| 5438983 | Falcone | Aug 1995 | A |
| 5462645 | Albery et al. | Oct 1995 | A |
| 5469846 | Khan | Nov 1995 | A |
| 5472317 | Field et al. | Dec 1995 | A |
| 5489414 | Schreiber et al. | Feb 1996 | A |
| 5491474 | Suni et al. | Feb 1996 | A |
| 5494562 | Maley et al. | Feb 1996 | A |
| 5496453 | Uenoyama et al. | Mar 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5507288 | Bocker et al. | Apr 1996 | A |
| 5509410 | Hill et al. | Apr 1996 | A |
| 5514718 | Lewis et al. | May 1996 | A |
| 5531878 | Vadgama et al. | Jul 1996 | A |
| 5533977 | Matcalf et al. | Jul 1996 | A |
| 5543326 | Heller et al. | Aug 1996 | A |
| 5545191 | Mann et al. | Aug 1996 | A |
| 5551427 | Altman | Sep 1996 | A |
| 5555190 | Derby et al. | Sep 1996 | A |
| 5560357 | Faupei et al. | Oct 1996 | A |
| 5562713 | Silvian | Oct 1996 | A |
| 5564434 | Halperin et al. | Oct 1996 | A |
| 5565085 | Ikeda et al. | Oct 1996 | A |
| 5567302 | Song et al. | Oct 1996 | A |
| 5568806 | Cheney, II et al. | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5575563 | Chiu et al. | Nov 1996 | A |
| 5582184 | Erickson et al. | Dec 1996 | A |
| 5582697 | Ikeda et al. | Dec 1996 | A |
| 5582698 | Flaherty et al. | Dec 1996 | A |
| 5584813 | Livingston et al. | Dec 1996 | A |
| 5586553 | Halili | Dec 1996 | A |
| 5589326 | Deng et al. | Dec 1996 | A |
| 5593852 | Heller et al. | Jan 1997 | A |
| 5596150 | Arndt et al. | Jan 1997 | A |
| 5601435 | Quy | Feb 1997 | A |
| 5609575 | Larson et al. | Mar 1997 | A |
| 5613978 | Harding | Mar 1997 | A |
| 5617851 | Lipkovker | Apr 1997 | A |
| 5628310 | Rao et al. | May 1997 | A |
| 5628324 | Sarbach | May 1997 | A |
| 5628890 | Carter et al. | May 1997 | A |
| 5632557 | Simons | May 1997 | A |
| 5651869 | Yoshioka et al. | Jul 1997 | A |
| 5653239 | Pompei et al. | Aug 1997 | A |
| 5660163 | Schulman et al. | Aug 1997 | A |
| 5665071 | Wyrick | Sep 1997 | A |
| 5665222 | Heller et al. | Sep 1997 | A |
| 5670031 | Hintsche et al. | Sep 1997 | A |
| 5680858 | Hansen et al. | Oct 1997 | A |
| 5682233 | Brinda | Oct 1997 | A |
| 5695623 | Michel et al. | Dec 1997 | A |
| 5708247 | McAleer et al. | Jan 1998 | A |
| 5711001 | Bussan et al. | Jan 1998 | A |
| 5711297 | Iliff et al. | Jan 1998 | A |
| 5711861 | Ward et al. | Jan 1998 | A |
| 5711862 | Sakoda et al. | Jan 1998 | A |
| 5726646 | Bane et al. | Mar 1998 | A |
| 5733044 | Rose et al. | Mar 1998 | A |
| 5735285 | Albert et al. | Apr 1998 | A |
| 5741211 | Renirie et al. | Apr 1998 | A |
| 5743262 | Lepper, Jr. et al. | Apr 1998 | A |
| 5746217 | Erickson et al. | May 1998 | A |
| 5746697 | Swedlow et al. | May 1998 | A |
| 5748103 | Flach et al. | May 1998 | A |
| 5749656 | Boehm et al. | May 1998 | A |
| 5766131 | Kondo et al. | Jun 1998 | A |
| 5771001 | Cobb | Jun 1998 | A |
| 5772586 | Heinonen et al. | Jun 1998 | A |
| 5779665 | Mastrototaro et al. | Jul 1998 | A |
| 5791344 | Schulman et al. | Aug 1998 | A |
| 5800420 | Gross et al. | Sep 1998 | A |
| 5807375 | Gross et al. | Sep 1998 | A |
| 5814020 | Gross | Sep 1998 | A |
| 5820551 | Hill et al. | Oct 1998 | A |
| 5820570 | Erickson et al. | Oct 1998 | A |
| 5820622 | Gross et al. | Oct 1998 | A |
| 5822715 | Worthington et al. | Oct 1998 | A |
| 5827184 | Netherly et al. | Oct 1998 | A |
| 5833603 | Kovacs et al. | Nov 1998 | A |
| 5840020 | Heinonen et al. | Nov 1998 | A |
| 5842983 | Abel et al. | Dec 1998 | A |
| 5851197 | Marano et al. | Dec 1998 | A |
| 5858001 | Tsals et al. | Jan 1999 | A |
| 5865804 | Bachynsky | Feb 1999 | A |
| 5885211 | Eppstein et al. | Mar 1999 | A |
| 5899855 | Brown | May 1999 | A |
| 5914026 | Blubaugh, Jr. et al. | Jun 1999 | A |
| 5918603 | Brown | Jul 1999 | A |
| 5919141 | Money et al. | Jul 1999 | A |
| 5924979 | Sedlow et al. | Jul 1999 | A |
| 5925021 | Castellano et al. | Jul 1999 | A |
| 5931814 | Alex et al. | Aug 1999 | A |
| 5931868 | Gross et al. | Aug 1999 | A |
| 5938679 | Freeman et al. | Aug 1999 | A |
| 5942979 | Luppino | Aug 1999 | A |
| 5948006 | Mann | Sep 1999 | A |
| 5951492 | Douglas et al. | Sep 1999 | A |
| 5951521 | Mastrototaro et al. | Sep 1999 | A |
| 5951582 | Thorne et al. | Sep 1999 | A |
| 5954643 | Van Antwerp | Sep 1999 | A |
| 5954685 | Tierny | Sep 1999 | A |
| 5957854 | Besson et al. | Sep 1999 | A |
| 5961451 | Reber et al. | Oct 1999 | A |
| 5964993 | Blubaugh, Jr. et al. | Oct 1999 | A |
| 5965380 | Heller et al. | Oct 1999 | A |
| 5971922 | Arita et al. | Oct 1999 | A |
| 5972199 | Heller et al. | Oct 1999 | A |
| 5987353 | Khatchatrian et al. | Nov 1999 | A |
| 5993411 | Choi | Nov 1999 | A |
| 5995860 | Sun et al. | Nov 1999 | A |
| 5997501 | Gross et al. | Dec 1999 | A |
| 6001067 | Shults et al. | Dec 1999 | A |
| 6004278 | Botich et al. | Dec 1999 | A |
| 6017335 | Burnham | Jan 2000 | A |
| 6022368 | Gavronsky et al. | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6026321 | Miyata et al. | Feb 2000 | A |
| 6027459 | Shain et al. | Feb 2000 | A |
| 6028413 | Brockmann | Feb 2000 | A |
| 6048352 | Douglas et al. | Apr 2000 | A |
| 6049727 | Crothall | Apr 2000 | A |
| 6052565 | Ishikura et al. | Apr 2000 | A |
| 6056718 | Funderburk et al. | May 2000 | A |
| 6059946 | Yukawa et al. | May 2000 | A |
| 6066243 | Anderson et al. | May 2000 | A |
| 6068399 | Tseng | May 2000 | A |
| 6071391 | Gotoh et al. | Jun 2000 | A |
| 6083710 | Heller et al. | Jul 2000 | A |
| 6088605 | Griffith et al. | Jul 2000 | A |
| 6088608 | Schulman et al. | Jul 2000 | A |
| 6091975 | Daddona et al. | Jul 2000 | A |
| 6091976 | Pfeiffer et al. | Jul 2000 | A |
| 6093172 | Funderburk et al. | Jul 2000 | A |
| 6096364 | Bok et al. | Aug 2000 | A |
| 6099484 | Douglas et al. | Aug 2000 | A |
| 6103033 | Say et al. | Aug 2000 | A |
| 6117290 | Say et al. | Sep 2000 | A |
| 6119028 | Schulman et al. | Sep 2000 | A |
| 6120676 | Heller et al. | Sep 2000 | A |
| 6121009 | Heller et al. | Sep 2000 | A |
| 6121611 | Lindsay et al. | Sep 2000 | A |
| 6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
| 6132449 | Lum et al. | Oct 2000 | A |
| 6134461 | Say et al. | Oct 2000 | A |
| 6143164 | Heller et al. | Nov 2000 | A |
| 6144837 | Quy | Nov 2000 | A |
| 6157850 | Diab et al. | Dec 2000 | A |
| 6159147 | Lichter et al. | Dec 2000 | A |
| 6161095 | Brown | Dec 2000 | A |
| 6162611 | Heller et al. | Dec 2000 | A |
| 6168606 | Levin et al. | Jan 2001 | B1 |
| 6175752 | Say et al. | Jan 2001 | B1 |
| 6186982 | Gross et al. | Feb 2001 | B1 |
| 6200265 | Walsh et al. | Mar 2001 | B1 |
| 6212416 | Ward et al. | Apr 2001 | B1 |
| 6219574 | Cormier et al. | Apr 2001 | B1 |
| 6223283 | Chaiken et al. | Apr 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6254536 | DeVito | Jul 2001 | B1 |
| 6254586 | Mann et al. | Jul 2001 | B1 |
| 6270455 | Brown | Aug 2001 | B1 |
| 6275717 | Gross et al. | Aug 2001 | B1 |
| 6283761 | Joao | Sep 2001 | B1 |
| 6283982 | Levaughn et al. | Sep 2001 | B1 |
| 6284478 | Heller et al. | Sep 2001 | B1 |
| 6293925 | Safabash et al. | Sep 2001 | B1 |
| 6295506 | Heinonen et al. | Sep 2001 | B1 |
| 6299757 | Feldman et al. | Oct 2001 | B1 |
| 6302866 | Marggi | Oct 2001 | B1 |
| 6306104 | Cunningham et al. | Oct 2001 | B1 |
| 6309884 | Cooper et al. | Oct 2001 | B1 |
| 6314317 | Willis | Nov 2001 | B1 |
| 6329161 | Heller et al. | Dec 2001 | B1 |
| 6331244 | Lewis et al. | Dec 2001 | B1 |
| 6338790 | Feldman et al. | Jan 2002 | B1 |
| 6348640 | Navot et al. | Feb 2002 | B1 |
| 6359270 | Bridson | Mar 2002 | B1 |
| 6359444 | Grimes | Mar 2002 | B1 |
| 6360888 | McIvor et al. | Mar 2002 | B1 |
| 6364890 | Lum et al. | Apr 2002 | B1 |
| 6366794 | Moussy et al. | Apr 2002 | B1 |
| 6368141 | Van Antwerp et al. | Apr 2002 | B1 |
| 6368274 | Van Antwerp et al. | Apr 2002 | B1 |
| 6377828 | Chaiken et al. | Apr 2002 | B1 |
| 6377894 | Deweese et al. | Apr 2002 | B1 |
| 6379301 | Worthington et al. | Apr 2002 | B1 |
| 6387048 | Schulman et al. | May 2002 | B1 |
| 6409740 | Kuhr et al. | Jun 2002 | B1 |
| 6413393 | Van Antwerp et al. | Jul 2002 | B1 |
| 6418332 | Mastrototaro et al. | Jul 2002 | B1 |
| 6424847 | Mastrototaro et al. | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6433743 | Massy et al. | Aug 2002 | B1 |
| 6435017 | Nowicki, Jr. et al. | Aug 2002 | B1 |
| 6437679 | Roques | Aug 2002 | B1 |
| 6440068 | Brown et al. | Aug 2002 | B1 |
| 6445374 | Albert et al. | Sep 2002 | B2 |
| 6461496 | Feldman et al. | Oct 2002 | B1 |
| 6471689 | Joseph et al. | Oct 2002 | B1 |
| 6478736 | Mault | Nov 2002 | B1 |
| 6482176 | Wich | Nov 2002 | B1 |
| 6484045 | Holker et al. | Nov 2002 | B1 |
| 6484046 | Say et al. | Nov 2002 | B1 |
| 6503381 | Gotoh et al. | Jan 2003 | B1 |
| 6514460 | Fendrock | Feb 2003 | B1 |
| 6514718 | Heller et al. | Feb 2003 | B2 |
| 6520326 | McIvor et al. | Feb 2003 | B2 |
| 6522927 | Bishay et al. | Feb 2003 | B1 |
| 6537242 | Palmer | Mar 2003 | B1 |
| 6540891 | Stewart et al. | Apr 2003 | B1 |
| 6546268 | Ishikawa et al. | Apr 2003 | B1 |
| 6551494 | Heller et al. | Apr 2003 | B1 |
| 6551496 | Moles et al. | Apr 2003 | B1 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6558320 | Causey, III et al. | May 2003 | B1 |
| 6558321 | Burd et al. | May 2003 | B1 |
| 6560471 | Heller et al. | May 2003 | B1 |
| 6561978 | Conn et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6565509 | Say et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6572566 | Effenhauser | Jun 2003 | B2 |
| 6574490 | Abbink et al. | Jun 2003 | B2 |
| 6575895 | Blair | Jun 2003 | B1 |
| 6576101 | Heller et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579690 | Bonnecaze et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6589229 | Connelly et al. | Jul 2003 | B1 |
| 6591125 | Buse et al. | Jul 2003 | B1 |
| 6592745 | Feldman et al. | Jul 2003 | B1 |
| 6595919 | Berner et al. | Jul 2003 | B2 |
| 6600997 | Deweese et al. | Jul 2003 | B2 |
| 6605200 | Mao et al. | Aug 2003 | B1 |
| 6605201 | Mao et al. | Aug 2003 | B1 |
| 6607509 | Bobroff et al. | Aug 2003 | B2 |
| 6610012 | Mault | Aug 2003 | B2 |
| 6616819 | Liamos et al. | Sep 2003 | B1 |
| 6618934 | Feldman et al. | Sep 2003 | B1 |
| 6631281 | Kastle | Oct 2003 | B1 |
| 6633772 | Ford et al. | Oct 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6641533 | Causey, III et al. | Nov 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6650471 | Doi | Nov 2003 | B2 |
| 6654625 | Say et al. | Nov 2003 | B1 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6666849 | Marshall et al. | Dec 2003 | B1 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6676290 | Lu | Jan 2004 | B1 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6689056 | Kilcoyne et al. | Feb 2004 | B1 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6695860 | Ward et al. | Feb 2004 | B1 |
| 6702857 | Brauker et al. | Mar 2004 | B2 |
| 6721582 | Trepagnier et al. | Apr 2004 | B2 |
| 6730025 | Platt | May 2004 | B1 |
| 6730200 | Stewart et al. | May 2004 | B1 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6736957 | Forrow et al. | May 2004 | B1 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6741877 | Shults et al. | May 2004 | B1 |
| 6746582 | Heller et al. | Jun 2004 | B2 |
| 6749740 | Liamos et al. | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6764581 | Forrow et al. | Jul 2004 | B1 |
| 6770030 | Schaupp et al. | Aug 2004 | B1 |
| 6773671 | Lewis et al. | Aug 2004 | B1 |
| 6790178 | Mault et al. | Sep 2004 | B1 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6830551 | Uchigaki | Dec 2004 | B1 |
| 6837858 | Cunningham et al. | Jan 2005 | B2 |
| 6837885 | Koblish et al. | Jan 2005 | B2 |
| 6837988 | Leong et al. | Jan 2005 | B2 |
| 6849052 | Ughigaki et al. | Feb 2005 | B2 |
| 6850790 | Berner et al. | Feb 2005 | B2 |
| 6854882 | Chen | Feb 2005 | B2 |
| 6862465 | Shults et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6881551 | Heller et al. | Apr 2005 | B2 |
| 6892085 | McIvor et al. | May 2005 | B2 |
| 6893545 | Gotoh et al. | May 2005 | B2 |
| 6895265 | Silver | May 2005 | B2 |
| 6923763 | Kovatchev et al. | Aug 2005 | B1 |
| 6931327 | Goode, Jr. et al. | Aug 2005 | B2 |
| 6932892 | Chen et al. | Aug 2005 | B2 |
| 6932894 | Mao et al. | Aug 2005 | B2 |
| 6936006 | Sabra | Aug 2005 | B2 |
| 6942518 | Liamos et al. | Sep 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6954662 | Freger et al. | Oct 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6959211 | Rule et al. | Oct 2005 | B2 |
| 6968294 | Gutta et al. | Nov 2005 | B2 |
| 6971274 | Olin | Dec 2005 | B2 |
| 6971999 | Py et al. | Dec 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6990366 | Say et al. | Jan 2006 | B2 |
| 6997907 | Safabash et al. | Feb 2006 | B2 |
| 6998247 | Monfre et al. | Feb 2006 | B2 |
| 6999854 | Roth | Feb 2006 | B2 |
| 7003336 | Holker et al. | Feb 2006 | B2 |
| 7003340 | Say et al. | Feb 2006 | B2 |
| 7003341 | Say et al. | Feb 2006 | B2 |
| 7010356 | Jog et al. | Mar 2006 | B2 |
| 7015817 | Copley et al. | Mar 2006 | B2 |
| 7016713 | Gardner et al. | Mar 2006 | B2 |
| 7022219 | Mansouri et al. | Apr 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025743 | Mann et al. | Apr 2006 | B2 |
| 7027848 | Robinson et al. | Apr 2006 | B2 |
| 7041057 | Faupel et al. | May 2006 | B1 |
| 7041068 | Freeman et al. | May 2006 | B2 |
| 7041468 | Drucker et al. | May 2006 | B2 |
| 7046153 | Oja et al. | May 2006 | B2 |
| 7052483 | Wojcik | May 2006 | B2 |
| 7056302 | Douglas | Jun 2006 | B2 |
| 7074307 | Simpson et al. | Jul 2006 | B2 |
| 7081195 | Simpson et al. | Jul 2006 | B2 |
| 7097637 | Triplett et al. | Aug 2006 | B2 |
| 7098803 | Mann et al. | Aug 2006 | B2 |
| 7108778 | Simpson et al. | Sep 2006 | B2 |
| 7110803 | Shults et al. | Sep 2006 | B2 |
| 7113821 | Sun et al. | Sep 2006 | B1 |
| 7118667 | Lee | Oct 2006 | B2 |
| 7120483 | Russel et al. | Oct 2006 | B2 |
| 7123950 | Mannheimer | Oct 2006 | B2 |
| 7134999 | Brauker et al. | Nov 2006 | B2 |
| 7136689 | Shults et al. | Nov 2006 | B2 |
| 7146202 | Ward et al. | Dec 2006 | B2 |
| 7155290 | Von Arx et al. | Dec 2006 | B2 |
| 7167818 | Brown | Jan 2007 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7174199 | Berner et al. | Feb 2007 | B2 |
| 7179226 | Crothall et al. | Feb 2007 | B2 |
| 7190988 | Say et al. | Mar 2007 | B2 |
| 7192450 | Brauker et al. | Mar 2007 | B2 |
| 7198606 | Boecker et al. | Apr 2007 | B2 |
| 7207974 | Safabash et al. | Apr 2007 | B2 |
| 7225535 | Feldman et al. | Jun 2007 | B2 |
| 7226442 | Sheppard et al. | Jun 2007 | B2 |
| 7226978 | Tapsak et al. | Jun 2007 | B2 |
| 7276029 | Goode, Jr. et al. | Oct 2007 | B2 |
| 7278983 | Ireland et al. | Oct 2007 | B2 |
| 7286894 | Grant et al. | Oct 2007 | B1 |
| 7297151 | Boecker et al. | Nov 2007 | B2 |
| 7299082 | Feldman et al. | Nov 2007 | B2 |
| 7310544 | Brister et al. | Dec 2007 | B2 |
| 7318816 | Bobroff et al. | Jan 2008 | B2 |
| 7324012 | Mann et al. | Jan 2008 | B2 |
| 7329239 | Safabash et al. | Feb 2008 | B2 |
| 7335294 | Heller et al. | Feb 2008 | B2 |
| 7340287 | Mason et al. | Mar 2008 | B2 |
| 7340309 | Miazga et al. | Mar 2008 | B2 |
| 7354420 | Steil et al. | Apr 2008 | B2 |
| 7364592 | Carr-Brendel et al. | Apr 2008 | B2 |
| 7366556 | Brister et al. | Apr 2008 | B2 |
| 7379765 | Petisce et al. | May 2008 | B2 |
| 7381184 | Funderburk et al. | Jun 2008 | B2 |
| 7402153 | Steil et al. | Jul 2008 | B2 |
| 7416541 | Yuzhakov et al. | Aug 2008 | B2 |
| 7424318 | Brister et al. | Sep 2008 | B2 |
| 7433727 | Ward et al. | Oct 2008 | B2 |
| 7455663 | Bikovsky | Nov 2008 | B2 |
| 7460898 | Brister et al. | Dec 2008 | B2 |
| 7462264 | Heller et al. | Dec 2008 | B2 |
| 7467003 | Brister et al. | Dec 2008 | B2 |
| 7468125 | Kraft et al. | Dec 2008 | B2 |
| 7471972 | Rhodes et al. | Dec 2008 | B2 |
| 7494465 | Brister et al. | Feb 2009 | B2 |
| 7497827 | Brister et al. | Mar 2009 | B2 |
| 7499002 | Blasko et al. | Mar 2009 | B2 |
| 7519408 | Rasdal et al. | Apr 2009 | B2 |
| 7583990 | Goode, Jr. et al. | Sep 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7599726 | Goode, Jr. et al. | Oct 2009 | B2 |
| 7604592 | Freeman et al. | Oct 2009 | B2 |
| 7613491 | Boock et al. | Nov 2009 | B2 |
| 7615007 | Shults et al. | Nov 2009 | B2 |
| 7632228 | Brauker et al. | Dec 2009 | B2 |
| 7635594 | Holmes et al. | Dec 2009 | B2 |
| 7637868 | Saint et al. | Dec 2009 | B2 |
| 7640048 | Dobbles et al. | Dec 2009 | B2 |
| 7651596 | Petisce et al. | Jan 2010 | B2 |
| 7651845 | Doyle, III et al. | Jan 2010 | B2 |
| 7654956 | Brister et al. | Feb 2010 | B2 |
| 7657297 | Simpson et al. | Feb 2010 | B2 |
| 7666149 | Simons et al. | Feb 2010 | B2 |
| 7682338 | Griffin | Mar 2010 | B2 |
| 7697967 | Stafford | Apr 2010 | B2 |
| 7699775 | Desai et al. | Apr 2010 | B2 |
| 7711402 | Shults et al. | May 2010 | B2 |
| 7713574 | Brister et al. | May 2010 | B2 |
| 7715893 | Kamath et al. | May 2010 | B2 |
| 7727147 | Osorio et al. | Jun 2010 | B1 |
| 7729737 | Ward | Jun 2010 | B2 |
| 7731657 | Stafford | Jun 2010 | B2 |
| 7736310 | Taub et al. | Jun 2010 | B2 |
| 7736344 | Moberg et al. | Jun 2010 | B2 |
| 7763042 | Iio et al. | Jul 2010 | B2 |
| 7766829 | Sloan et al. | Aug 2010 | B2 |
| 7768387 | Fennell et al. | Aug 2010 | B2 |
| 7771352 | Shults et al. | Aug 2010 | B2 |
| 7775444 | DeRocco et al. | Aug 2010 | B2 |
| 7783333 | Brister et al. | Aug 2010 | B2 |
| 7792562 | Shults et al. | Sep 2010 | B2 |
| 7811231 | Jin et al. | Oct 2010 | B2 |
| 7813809 | Strother et al. | Oct 2010 | B2 |
| 7822454 | Alden et al. | Oct 2010 | B1 |
| 7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
| 7866026 | Wang et al. | Jan 2011 | B1 |
| 7889069 | Fifolt et al. | Feb 2011 | B2 |
| 7899511 | Shults et al. | Mar 2011 | B2 |
| 7899545 | John | Mar 2011 | B2 |
| 7905833 | Brister et al. | Mar 2011 | B2 |
| 7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
| 7920906 | Goode et al. | Apr 2011 | B2 |
| 7920907 | McGarraugh et al. | Apr 2011 | B2 |
| 7938797 | Estes | May 2011 | B2 |
| 7941200 | Weinert et al. | May 2011 | B2 |
| 7946985 | Mastrototaro et al. | May 2011 | B2 |
| 7970448 | Shults et al. | Jun 2011 | B2 |
| 7970449 | Ward | Jun 2011 | B2 |
| 7972296 | Braig et al. | Jul 2011 | B2 |
| 7974672 | Shults et al. | Jul 2011 | B2 |
| 7978063 | Baldus et al. | Jul 2011 | B2 |
| 7996158 | Hayter et al. | Aug 2011 | B2 |
| 8005524 | Brauker et al. | Aug 2011 | B2 |
| 8010174 | Goode et al. | Aug 2011 | B2 |
| 8010256 | Oowada | Aug 2011 | B2 |
| 8103471 | Hayter | Jan 2012 | B2 |
| 8140312 | Hayter et al. | Mar 2012 | B2 |
| 8160670 | Quyang et al. | Apr 2012 | B2 |
| 8160900 | Taub et al. | Apr 2012 | B2 |
| 8192394 | Estes et al. | Jun 2012 | B2 |
| 8216138 | McGarraugh et al. | Jul 2012 | B1 |
| 8224410 | Hadvary et al. | Jul 2012 | B2 |
| 8239166 | Hayter et al. | Aug 2012 | B2 |
| 8255026 | Al-Ali | Aug 2012 | B1 |
| 8260558 | Hayter et al. | Sep 2012 | B2 |
| 8282549 | Brauker et al. | Oct 2012 | B2 |
| 8346335 | Harper et al. | Jan 2013 | B2 |
| 8346337 | Heller et al. | Jan 2013 | B2 |
| 8374668 | Hayter et al. | Feb 2013 | B1 |
| 8376945 | Hayter et al. | Feb 2013 | B2 |
| 8377271 | Mao et al. | Feb 2013 | B2 |
| 8409093 | Bugler | Apr 2013 | B2 |
| 8444560 | Hayter et al. | May 2013 | B2 |
| 8461985 | Fennell et al. | Jun 2013 | B2 |
| 8512243 | Stafford | Aug 2013 | B2 |
| 8560038 | Hayter et al. | Oct 2013 | B2 |
| 8571808 | Hayter | Oct 2013 | B2 |
| 8583205 | Budiman et al. | Nov 2013 | B2 |
| 8597570 | Terashima et al. | Dec 2013 | B2 |
| 8600681 | Hayter et al. | Dec 2013 | B2 |
| 8612163 | Hayter et al. | Dec 2013 | B2 |
| 8682408 | Boock et al. | Mar 2014 | B2 |
| 8682615 | Hayter et al. | Mar 2014 | B2 |
| 8710993 | Hayter et al. | Apr 2014 | B2 |
| 8834366 | Hayter et al. | Sep 2014 | B2 |
| 8845536 | Brauker et al. | Sep 2014 | B2 |
| 9060719 | Hayter et al. | Jun 2015 | B2 |
| 9186098 | Lee et al. | Nov 2015 | B2 |
| 9289179 | Hayter et al. | Mar 2016 | B2 |
| 9357951 | Simpson et al. | Jun 2016 | B2 |
| 9398872 | Hayter et al. | Jul 2016 | B2 |
| 9439586 | Bugler | Sep 2016 | B2 |
| 9480421 | Stafford | Nov 2016 | B2 |
| 9483608 | Hayter et al. | Nov 2016 | B2 |
| 9558325 | Hayter et al. | Jan 2017 | B2 |
| 20010034479 | Ring et al. | Oct 2001 | A1 |
| 20010037366 | Webb et al. | Nov 2001 | A1 |
| 20020002344 | Douglas et al. | Jan 2002 | A1 |
| 20020013538 | Teller | Jan 2002 | A1 |
| 20020016534 | Trepagnier et al. | Feb 2002 | A1 |
| 20020019022 | Dunn et al. | Feb 2002 | A1 |
| 20020022855 | Bobroff et al. | Feb 2002 | A1 |
| 20020023852 | Mclvor et al. | Feb 2002 | A1 |
| 20020032386 | Sackner et al. | Mar 2002 | A1 |
| 20020042090 | Heller et al. | Apr 2002 | A1 |
| 20020050250 | Peterson et al. | May 2002 | A1 |
| 20020055711 | Lavi et al. | May 2002 | A1 |
| 20020057993 | Maisey et al. | May 2002 | A1 |
| 20020065454 | Lebel et al. | May 2002 | A1 |
| 20020066764 | Perry et al. | Jun 2002 | A1 |
| 20020072720 | Hague et al. | Jun 2002 | A1 |
| 20020076966 | Carron et al. | Jun 2002 | A1 |
| 20020082487 | Kollias et al. | Jun 2002 | A1 |
| 20020095076 | Krausman et al. | Jul 2002 | A1 |
| 20020103499 | Perez et al. | Aug 2002 | A1 |
| 20020106709 | Potts et al. | Aug 2002 | A1 |
| 20020117639 | Paolini et al. | Aug 2002 | A1 |
| 20020119711 | VanAntwerp et al. | Aug 2002 | A1 |
| 20020120186 | Keimel | Aug 2002 | A1 |
| 20020128594 | Das et al. | Sep 2002 | A1 |
| 20020130042 | Moerman et al. | Sep 2002 | A1 |
| 20020133066 | Miller et al. | Sep 2002 | A1 |
| 20020147135 | Schnell | Oct 2002 | A1 |
| 20020150959 | Lejeunne et al. | Oct 2002 | A1 |
| 20020154050 | Krupp et al. | Oct 2002 | A1 |
| 20020161288 | Shin et al. | Oct 2002 | A1 |
| 20020161290 | Chance | Oct 2002 | A1 |
| 20020165462 | Westbrook et al. | Nov 2002 | A1 |
| 20020169369 | Ward et al. | Nov 2002 | A1 |
| 20020198444 | Ughigaki et al. | Dec 2002 | A1 |
| 20030023189 | Kuo | Jan 2003 | A1 |
| 20030023317 | Brauker et al. | Jan 2003 | A1 |
| 20030023461 | Quintanilla et al. | Jan 2003 | A1 |
| 20030028089 | Galley et al. | Feb 2003 | A1 |
| 20030032077 | Itoh et al. | Feb 2003 | A1 |
| 20030032867 | Crothall et al. | Feb 2003 | A1 |
| 20030032874 | Rhodes et al. | Feb 2003 | A1 |
| 20030042137 | Mao et al. | Mar 2003 | A1 |
| 20030050546 | Desai et al. | Mar 2003 | A1 |
| 20030054428 | Monfre et al. | Mar 2003 | A1 |
| 20030060753 | Starkweather et al. | Mar 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030069510 | Semler | Apr 2003 | A1 |
| 20030078481 | McIvor et al. | Apr 2003 | A1 |
| 20030078560 | Miller et al. | Apr 2003 | A1 |
| 20030083686 | Freeman | May 2003 | A1 |
| 20030097092 | Flaherty | May 2003 | A1 |
| 20030100040 | Bonnecaze et al. | May 2003 | A1 |
| 20030100821 | Heller | May 2003 | A1 |
| 20030109775 | O'Neil et al. | Jun 2003 | A1 |
| 20030114897 | Von Arx et al. | Jun 2003 | A1 |
| 20030134347 | Heller et al. | Jul 2003 | A1 |
| 20030135127 | Sackner et al. | Jul 2003 | A1 |
| 20030135333 | Aceti et al. | Jul 2003 | A1 |
| 20030144581 | Conn et al. | Jul 2003 | A1 |
| 20030144608 | Kojima et al. | Jul 2003 | A1 |
| 20030155656 | Chiu et al. | Aug 2003 | A1 |
| 20030168338 | Gao et al. | Sep 2003 | A1 |
| 20030176933 | Lebel et al. | Sep 2003 | A1 |
| 20030187338 | Say et al. | Oct 2003 | A1 |
| 20030199744 | Buse et al. | Oct 2003 | A1 |
| 20030199790 | Boecker et al. | Oct 2003 | A1 |
| 20030199910 | Boecker et al. | Oct 2003 | A1 |
| 20030212379 | Bylund et al. | Nov 2003 | A1 |
| 20030217966 | Tapsak et al. | Nov 2003 | A1 |
| 20030225361 | Sabra | Dec 2003 | A1 |
| 20040002682 | Kovelman et al. | Jan 2004 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040011671 | Shults et al. | Jan 2004 | A1 |
| 20040034289 | Teller et al. | Feb 2004 | A1 |
| 20040040840 | Mao et al. | Mar 2004 | A1 |
| 20040045879 | Shults et al. | Mar 2004 | A1 |
| 20040054263 | Moerman et al. | Mar 2004 | A1 |
| 20040063435 | Sakamoto et al. | Apr 2004 | A1 |
| 20040064068 | DeNuzzio et al. | Apr 2004 | A1 |
| 20040064133 | Miller et al. | Apr 2004 | A1 |
| 20040072357 | Steine et al. | Apr 2004 | A1 |
| 20040096959 | Steine et al. | May 2004 | A1 |
| 20040106858 | Say et al. | Jun 2004 | A1 |
| 20040106859 | Say et al. | Jun 2004 | A1 |
| 20040111017 | Say et al. | Jun 2004 | A1 |
| 20040116847 | Wall | Jun 2004 | A1 |
| 20040116865 | Bengtsson | Jun 2004 | A1 |
| 20040117204 | Mazar et al. | Jun 2004 | A1 |
| 20040122353 | Shahmirian et al. | Jun 2004 | A1 |
| 20040122489 | Mazar et al. | Jun 2004 | A1 |
| 20040116866 | Gorman et al. | Jul 2004 | A1 |
| 20040133164 | Funderburk | Jul 2004 | A1 |
| 20040133390 | Osorio et al. | Jul 2004 | A1 |
| 20040135571 | Uutela et al. | Jul 2004 | A1 |
| 20040135684 | Steinthal et al. | Jul 2004 | A1 |
| 20040138544 | Ward et al. | Jul 2004 | A1 |
| 20040138588 | Saikley et al. | Jul 2004 | A1 |
| 20040138688 | Giraud | Jul 2004 | A1 |
| 20040140211 | Broy et al. | Jul 2004 | A1 |
| 20040142403 | Hetzel et al. | Jul 2004 | A1 |
| 20040147872 | Thompson | Jul 2004 | A1 |
| 20040147996 | Miazga et al. | Jul 2004 | A1 |
| 20040152622 | Keith et al. | Aug 2004 | A1 |
| 20040158207 | Hunn et al. | Aug 2004 | A1 |
| 20040162521 | Bengtsson et al. | Aug 2004 | A1 |
| 20040162678 | Hetzel et al. | Aug 2004 | A1 |
| 20040167801 | Say et al. | Aug 2004 | A1 |
| 20040171910 | Moore-Steele | Sep 2004 | A1 |
| 20040171921 | Say et al. | Sep 2004 | A1 |
| 20040176672 | Silver et al. | Sep 2004 | A1 |
| 20040186362 | Brauker et al. | Sep 2004 | A1 |
| 20040186365 | Jin et al. | Sep 2004 | A1 |
| 20040193020 | Chiba et al. | Sep 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20040199056 | Husemann et al. | Oct 2004 | A1 |
| 20040199059 | Brauker et al. | Oct 2004 | A1 |
| 20040204687 | Mogensen et al. | Oct 2004 | A1 |
| 20040210122 | Sleburg | Oct 2004 | A1 |
| 20040223985 | Dunfiled et al. | Nov 2004 | A1 |
| 20040225338 | Lebel et al. | Nov 2004 | A1 |
| 20040236200 | Say et al. | Nov 2004 | A1 |
| 20040236251 | Roe et al. | Nov 2004 | A1 |
| 20040249253 | Racchini et al. | Dec 2004 | A1 |
| 20040254433 | Bandis et al. | Dec 2004 | A1 |
| 20040254434 | Goodnow et al. | Dec 2004 | A1 |
| 20040267300 | Mace | Dec 2004 | A1 |
| 20050001024 | Kusaka et al. | Jan 2005 | A1 |
| 20050003470 | Nelson et al. | Jan 2005 | A1 |
| 20050004494 | Perez et al. | Jan 2005 | A1 |
| 20050006122 | Burnette | Jan 2005 | A1 |
| 20050010269 | Lebel et al. | Jan 2005 | A1 |
| 20050017864 | Tsoukalis | Jan 2005 | A1 |
| 20050027177 | Shin et al. | Feb 2005 | A1 |
| 20050027180 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050027181 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050027462 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050027463 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050031689 | Shults et al. | Feb 2005 | A1 |
| 20050033132 | Shults et al. | Feb 2005 | A1 |
| 20050043598 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050049179 | Davidson et al. | Mar 2005 | A1 |
| 20050051427 | Brauker et al. | Mar 2005 | A1 |
| 20050051440 | Simpson et al. | Mar 2005 | A1 |
| 20050056552 | Simpson | Mar 2005 | A1 |
| 20050070774 | Addison et al. | Mar 2005 | A1 |
| 20050070819 | Poux et al. | Mar 2005 | A1 |
| 20050085872 | Yanagihara et al. | Apr 2005 | A1 |
| 20050090607 | Tapsak et al. | Apr 2005 | A1 |
| 20050090850 | Thoes et al. | Apr 2005 | A1 |
| 20050096516 | Soykan et al. | May 2005 | A1 |
| 20050096520 | Maekawa et al. | May 2005 | A1 |
| 20050101912 | Faust et al. | May 2005 | A1 |
| 20050106713 | Phan et al. | May 2005 | A1 |
| 20050112169 | Brauker et al. | May 2005 | A1 |
| 20050113648 | Yang et al. | May 2005 | A1 |
| 20050113886 | Fischell et al. | May 2005 | A1 |
| 20050114068 | Chey et al. | May 2005 | A1 |
| 20050115832 | Simpson et al. | Jun 2005 | A1 |
| 20050116683 | Cheng et al. | Jun 2005 | A1 |
| 20050121322 | Say et al. | Jun 2005 | A1 |
| 20050131346 | Douglas | Jun 2005 | A1 |
| 20050134731 | Lee et al. | Jun 2005 | A1 |
| 20050137530 | Campbell et al. | Jun 2005 | A1 |
| 20050143635 | Kamath et al. | Jun 2005 | A1 |
| 20050154271 | Rasdal et al. | Jul 2005 | A1 |
| 20050154410 | Conway et al. | Jul 2005 | A1 |
| 20050159678 | Taniike et al. | Jul 2005 | A1 |
| 20050161346 | Simpson et al. | Jul 2005 | A1 |
| 20050165404 | Miller | Jul 2005 | A1 |
| 20050173245 | Feldman et al. | Aug 2005 | A1 |
| 20050176136 | Burd et al. | Aug 2005 | A1 |
| 20050182306 | Sloan | Aug 2005 | A1 |
| 20050187442 | Cho et al. | Aug 2005 | A1 |
| 20050187720 | Goode, Jr. et al. | Aug 2005 | A1 |
| 20050192557 | Brauker et al. | Sep 2005 | A1 |
| 20050195930 | Spital et al. | Sep 2005 | A1 |
| 20050197554 | Polcha | Sep 2005 | A1 |
| 20050197793 | Baker, Jr. | Sep 2005 | A1 |
| 20050199494 | Say et al. | Sep 2005 | A1 |
| 20050203360 | Brauker et al. | Sep 2005 | A1 |
| 20050204134 | Von Arx et al. | Sep 2005 | A1 |
| 20050214892 | Kovatchev et al. | Sep 2005 | A1 |
| 20050222518 | Dib | Oct 2005 | A1 |
| 20050222599 | Czernecki et al. | Oct 2005 | A1 |
| 20050236277 | Imran et al. | Oct 2005 | A9 |
| 20050236361 | Ufer et al. | Oct 2005 | A1 |
| 20050239154 | Feldman et al. | Oct 2005 | A1 |
| 20050239156 | Drucker et al. | Oct 2005 | A1 |
| 20050241957 | Mao et al. | Nov 2005 | A1 |
| 20050245795 | Goode, Jr. et al. | Nov 2005 | A1 |
| 20050245799 | Brauker et al. | Nov 2005 | A1 |
| 20050245839 | Stivoric et al. | Nov 2005 | A1 |
| 20050245844 | Mace et al. | Nov 2005 | A1 |
| 20050251033 | Scarantino et al. | Nov 2005 | A1 |
| 20050267327 | Iizuka et al. | Dec 2005 | A1 |
| 20050269214 | Lee | Dec 2005 | A1 |
| 20050277164 | Drucker et al. | Dec 2005 | A1 |
| 20050277912 | John | Dec 2005 | A1 |
| 20050283114 | Bresina et al. | Dec 2005 | A1 |
| 20050287620 | Heller et al. | Dec 2005 | A1 |
| 20060001538 | Kraft et al. | Jan 2006 | A1 |
| 20060004303 | Weidenhaupt et al. | Jan 2006 | A1 |
| 20060009727 | O'Mahony et al. | Jan 2006 | A1 |
| 20060010098 | Goodnow et al. | Jan 2006 | A1 |
| 20060015020 | Neale et al. | Jan 2006 | A1 |
| 20060015024 | Brister et al. | Jan 2006 | A1 |
| 20060016700 | Brister et al. | Jan 2006 | A1 |
| 20060019327 | Brister et al. | Jan 2006 | A1 |
| 20060020186 | Brister et al. | Jan 2006 | A1 |
| 20060020187 | Brister et al. | Jan 2006 | A1 |
| 20060020188 | Kamath et al. | Jan 2006 | A1 |
| 20060020189 | Brister et al. | Jan 2006 | A1 |
| 20060020190 | Kamath et al. | Jan 2006 | A1 |
| 20060020191 | Brister et al. | Jan 2006 | A1 |
| 20060020192 | Brister et al. | Jan 2006 | A1 |
| 20060020300 | Nghiem et al. | Jan 2006 | A1 |
| 20060025662 | Buse et al. | Feb 2006 | A1 |
| 20060025663 | Talbot et al. | Feb 2006 | A1 |
| 20060036139 | Brister et al. | Feb 2006 | A1 |
| 20060036140 | Brister et al. | Feb 2006 | A1 |
| 20060036141 | Kamath et al. | Feb 2006 | A1 |
| 20060036142 | Brister et al. | Feb 2006 | A1 |
| 20060036143 | Brister et al. | Feb 2006 | A1 |
| 20060036144 | Brister et al. | Feb 2006 | A1 |
| 20060036145 | Brister et al. | Feb 2006 | A1 |
| 20060040402 | Brauker et al. | Feb 2006 | A1 |
| 20060047220 | Sakata et al. | Mar 2006 | A1 |
| 20060058588 | Zdeblick | Mar 2006 | A1 |
| 20060068208 | Tapsak et al. | Mar 2006 | A1 |
| 20060079740 | Silver et al. | Apr 2006 | A1 |
| 20060086624 | Tapsak et al. | Apr 2006 | A1 |
| 20060091006 | Wang et al. | May 2006 | A1 |
| 20060095014 | Ethelfeld | May 2006 | A1 |
| 20060129173 | Wilkinson | Jun 2006 | A1 |
| 20060135908 | Liniger et al. | Jun 2006 | A1 |
| 20060142651 | Brister et al. | Jun 2006 | A1 |
| 20060154642 | Scannell | Jul 2006 | A1 |
| 20060155180 | Brister et al. | Jul 2006 | A1 |
| 20060155210 | Beckman et al. | Jul 2006 | A1 |
| 20060155317 | List et al. | Jul 2006 | A1 |
| 20060166629 | Reggiardo | Jul 2006 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060183984 | Dobbles et al. | Aug 2006 | A1 |
| 20060183985 | Brister et al. | Aug 2006 | A1 |
| 20060189851 | Tvig et al. | Aug 2006 | A1 |
| 20060189863 | Peyser et al. | Aug 2006 | A1 |
| 20060189939 | Gonnelli et al. | Aug 2006 | A1 |
| 20060193375 | Lee | Aug 2006 | A1 |
| 20060195029 | Shults et al. | Aug 2006 | A1 |
| 20060200020 | Brister et al. | Sep 2006 | A1 |
| 20060200022 | Brauker et al. | Sep 2006 | A1 |
| 20060200181 | Fukuzawa et al. | Sep 2006 | A1 |
| 20060200970 | Brister et al. | Sep 2006 | A1 |
| 20060202805 | Schulman et al. | Sep 2006 | A1 |
| 20060211921 | Brauker et al. | Sep 2006 | A1 |
| 20060222566 | Brauker et al. | Oct 2006 | A1 |
| 20060224108 | Brauker et al. | Oct 2006 | A1 |
| 20060224109 | Steil et al. | Oct 2006 | A1 |
| 20060224141 | Rush et al. | Oct 2006 | A1 |
| 20060226985 | Goodnow et al. | Oct 2006 | A1 |
| 20060247508 | Fennell | Nov 2006 | A1 |
| 20060247985 | Liamos et al. | Nov 2006 | A1 |
| 20060253086 | Moberg et al. | Nov 2006 | A1 |
| 20060258929 | Goode, Jr. et al. | Nov 2006 | A1 |
| 20060258939 | Pesach et al. | Nov 2006 | A1 |
| 20060258959 | Sode | Nov 2006 | A1 |
| 20060264888 | Moberg et al. | Nov 2006 | A1 |
| 20060270922 | Brauker et al. | Nov 2006 | A1 |
| 20060270923 | Brauker et al. | Nov 2006 | A1 |
| 20060276724 | Freeman | Dec 2006 | A1 |
| 20060281985 | Ward et al. | Dec 2006 | A1 |
| 20060282042 | Walters et al. | Dec 2006 | A1 |
| 20060287591 | Ocvirk et al. | Dec 2006 | A1 |
| 20060290496 | Peeters et al. | Dec 2006 | A1 |
| 20060293607 | Alt et al. | Dec 2006 | A1 |
| 20070007133 | Mang et al. | Jan 2007 | A1 |
| 20070016381 | Kamath et al. | Jan 2007 | A1 |
| 20070017983 | Frank et al. | Jan 2007 | A1 |
| 20070027381 | Stafford | Feb 2007 | A1 |
| 20070027384 | Brister et al. | Feb 2007 | A1 |
| 20070027385 | Brister et al. | Feb 2007 | A1 |
| 20070027507 | Burdett et al. | Feb 2007 | A1 |
| 20070032706 | Kamath et al. | Feb 2007 | A1 |
| 20070032717 | Brister et al. | Feb 2007 | A1 |
| 20070032718 | Shults et al. | Feb 2007 | A1 |
| 20070038044 | Dobbles et al. | Feb 2007 | A1 |
| 20070045902 | Brauker et al. | Mar 2007 | A1 |
| 20070056858 | Chen et al. | Mar 2007 | A1 |
| 20070060814 | Stafford | Mar 2007 | A1 |
| 20070060869 | Tolle et al. | Mar 2007 | A1 |
| 20070068807 | Feldman et al. | Mar 2007 | A1 |
| 20070073129 | Shah et al. | Mar 2007 | A1 |
| 20070078320 | Stafford | Apr 2007 | A1 |
| 20070078321 | Mazza et al. | Apr 2007 | A1 |
| 20070078322 | Stafford | Apr 2007 | A1 |
| 20070088377 | Levaughn et al. | Apr 2007 | A1 |
| 20070093704 | Brister et al. | Apr 2007 | A1 |
| 20070093754 | Mogensen et al. | Apr 2007 | A1 |
| 20070093786 | Goldsmith et al. | Apr 2007 | A1 |
| 20070095661 | Wang et al. | May 2007 | A1 |
| 20070106135 | Sloan et al. | May 2007 | A1 |
| 20070108048 | Wang et al. | May 2007 | A1 |
| 20070110124 | Shiraki et al. | May 2007 | A1 |
| 20070123819 | Mernoe et al. | May 2007 | A1 |
| 20070129619 | Ward et al. | Jun 2007 | A1 |
| 20070129621 | Kellogg et al. | Jun 2007 | A1 |
| 20070135696 | Ward | Jun 2007 | A1 |
| 20070149873 | Say et al. | Jun 2007 | A1 |
| 20070149875 | Ouyang et al. | Jun 2007 | A1 |
| 20070153705 | Rosar et al. | Jul 2007 | A1 |
| 20070156094 | Safabash et al. | Jul 2007 | A1 |
| 20070163880 | Woo et al. | Jul 2007 | A1 |
| 20070173706 | Neinast et al. | Jul 2007 | A1 |
| 20070173709 | Petisce et al. | Jul 2007 | A1 |
| 20070173710 | Petisce et al. | Jul 2007 | A1 |
| 20070173741 | Deshmukh et al. | Jul 2007 | A1 |
| 20070191701 | Feldman et al. | Aug 2007 | A1 |
| 20070191702 | Yodfat et al. | Aug 2007 | A1 |
| 20070197889 | Brister et al. | Aug 2007 | A1 |
| 20070199818 | Petyt et al. | Aug 2007 | A1 |
| 20070202562 | Curry et al. | Aug 2007 | A1 |
| 20070203407 | Hoss et al. | Aug 2007 | A1 |
| 20070203966 | Brauker et al. | Aug 2007 | A1 |
| 20070208244 | Brauker et al. | Sep 2007 | A1 |
| 20070208245 | Brauker et al. | Sep 2007 | A1 |
| 20070208246 | Brauker et al. | Sep 2007 | A1 |
| 20070213611 | Simpson et al. | Sep 2007 | A1 |
| 20070219496 | Kamen et al. | Sep 2007 | A1 |
| 20070227911 | Wang et al. | Oct 2007 | A1 |
| 20070232878 | Kovatchev et al. | Oct 2007 | A1 |
| 20070232879 | Brister et al. | Oct 2007 | A1 |
| 20070233013 | Schoenberg et al. | Oct 2007 | A1 |
| 20070235331 | Simpson et al. | Oct 2007 | A1 |
| 20070244368 | Bayloff et al. | Oct 2007 | A1 |
| 20070244379 | Boock et al. | Oct 2007 | A1 |
| 20070244398 | Lo et al. | Oct 2007 | A1 |
| 20070249922 | Peyser et al. | Oct 2007 | A1 |
| 20070255302 | Koeppel et al. | Nov 2007 | A1 |
| 20070255321 | Gerber et al. | Nov 2007 | A1 |
| 20070255348 | Holtzclaw | Nov 2007 | A1 |
| 20070270672 | Hayter | Nov 2007 | A1 |
| 20080004512 | Funderburk et al. | Jan 2008 | A1 |
| 20080004515 | Jennewine et al. | Jan 2008 | A1 |
| 20080004573 | Kaufmann et al. | Jan 2008 | A1 |
| 20080004601 | Jennewine et al. | Jan 2008 | A1 |
| 20080009692 | Stafford | Jan 2008 | A1 |
| 20080009805 | Ethelfeld | Jan 2008 | A1 |
| 20080017522 | Heller et al. | Jan 2008 | A1 |
| 20080021666 | Goode, Jr. et al. | Jan 2008 | A1 |
| 20080027296 | Hadvary et al. | Jan 2008 | A1 |
| 20080027474 | Curry et al. | Jan 2008 | A1 |
| 20080029391 | Mao et al. | Feb 2008 | A1 |
| 20080033254 | Kamath et al. | Feb 2008 | A1 |
| 20080033268 | Stafford | Feb 2008 | A1 |
| 20080033318 | Mace et al. | Feb 2008 | A1 |
| 20080039702 | Hayter et al. | Feb 2008 | A1 |
| 20080045824 | Tapsak et al. | Feb 2008 | A1 |
| 20080057484 | Miyata et al. | Mar 2008 | A1 |
| 20080058625 | McGarraugh et al. | Mar 2008 | A1 |
| 20080058626 | Miyata et al. | Mar 2008 | A1 |
| 20080058678 | Miyata et al. | Mar 2008 | A1 |
| 20080058773 | John | Mar 2008 | A1 |
| 20080060955 | Goodnow | Mar 2008 | A1 |
| 20080061961 | John | Mar 2008 | A1 |
| 20080064937 | McGarraugh et al. | Mar 2008 | A1 |
| 20080064941 | Funderburk et al. | Mar 2008 | A1 |
| 20080064944 | VanAntwerp et al. | Mar 2008 | A1 |
| 20080065646 | Zhang et al. | Mar 2008 | A1 |
| 20080066305 | Wang et al. | Mar 2008 | A1 |
| 20080071156 | Brister et al. | Mar 2008 | A1 |
| 20080071157 | McGarraugh et al. | Mar 2008 | A1 |
| 20080071158 | McGarraugh et al. | Mar 2008 | A1 |
| 20080083617 | Simpson et al. | Apr 2008 | A1 |
| 20080086042 | Brister et al. | Apr 2008 | A1 |
| 20080086044 | Brister et al. | Apr 2008 | A1 |
| 20080086273 | Shults et al. | Apr 2008 | A1 |
| 20080092638 | Brenneman et al. | Apr 2008 | A1 |
| 20080097246 | Stafford | Apr 2008 | A1 |
| 20080099332 | Scott et al. | May 2008 | A1 |
| 20080102441 | Chen et al. | May 2008 | A1 |
| 20080108942 | Brister et al. | May 2008 | A1 |
| 20080112848 | Huffstodt et al. | May 2008 | A1 |
| 20080114228 | McCluskey et al. | May 2008 | A1 |
| 20080114280 | Stafford | May 2008 | A1 |
| 20080119707 | Stafford | May 2008 | A1 |
| 20080133702 | Sharma et al. | Jun 2008 | A1 |
| 20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
| 20080148873 | Wang | Jun 2008 | A1 |
| 20080161664 | Mastrototaro et al. | Jul 2008 | A1 |
| 20080167578 | Bryer et al. | Jul 2008 | A1 |
| 20080177149 | Weinert et al. | Jul 2008 | A1 |
| 20080177165 | Blomquist et al. | Jul 2008 | A1 |
| 20080183061 | Goode, Jr. et al. | Jul 2008 | A1 |
| 20080183399 | Goode, Jr. et al. | Jul 2008 | A1 |
| 20080188731 | Brister et al. | Aug 2008 | A1 |
| 20080189051 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194934 | Ray et al. | Aug 2008 | A1 |
| 20080194935 | Brister et al. | Aug 2008 | A1 |
| 20080194936 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194937 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194938 | Brister et al. | Aug 2008 | A1 |
| 20080195049 | Thalmann et al. | Aug 2008 | A1 |
| 20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
| 20080195967 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080197024 | Simpson et al. | Aug 2008 | A1 |
| 20080200788 | Brister et al. | Aug 2008 | A1 |
| 20080200789 | Brister et al. | Aug 2008 | A1 |
| 20080200791 | Simpson et al. | Aug 2008 | A1 |
| 20080200897 | Hoss et al. | Aug 2008 | A1 |
| 20080201325 | Doniger et al. | Aug 2008 | A1 |
| 20080208025 | Shults et al. | Aug 2008 | A1 |
| 20080208026 | Noujaim et al. | Aug 2008 | A1 |
| 20080214481 | Challoner et al. | Sep 2008 | A1 |
| 20080214900 | Fennell et al. | Sep 2008 | A1 |
| 20080214910 | Buck | Sep 2008 | A1 |
| 20080214915 | Brister et al. | Sep 2008 | A1 |
| 20080214918 | Brister et al. | Sep 2008 | A1 |
| 20080228051 | Shults et al. | Sep 2008 | A1 |
| 20080228054 | Shults et al. | Sep 2008 | A1 |
| 20080234943 | Ray et al. | Sep 2008 | A1 |
| 20080242961 | Brister et al. | Oct 2008 | A1 |
| 20080242963 | Essenpreis et al. | Oct 2008 | A1 |
| 20080254544 | Modzelewski et al. | Oct 2008 | A1 |
| 20080255440 | Eilersen et al. | Oct 2008 | A1 |
| 20080262330 | Reynolds et al. | Oct 2008 | A1 |
| 20080262469 | Brister et al. | Oct 2008 | A1 |
| 20080267823 | Wang et al. | Oct 2008 | A1 |
| 20080269584 | Shekalim | Oct 2008 | A1 |
| 20080269673 | Butoi et al. | Oct 2008 | A1 |
| 20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
| 20080275313 | Brister et al. | Nov 2008 | A1 |
| 20080281178 | Chuang et al. | Nov 2008 | A1 |
| 20080283396 | Wang et al. | Nov 2008 | A1 |
| 20080287764 | Rasdal et al. | Nov 2008 | A1 |
| 20080287765 | Rasdal et al. | Nov 2008 | A1 |
| 20080287766 | Rasdal et al. | Nov 2008 | A1 |
| 20080294024 | Cosentino et al. | Nov 2008 | A1 |
| 20080294096 | Uber et al. | Nov 2008 | A1 |
| 20080296155 | Shults et al. | Dec 2008 | A1 |
| 20080300476 | Stafford | Dec 2008 | A1 |
| 20080300572 | Rankers et al. | Dec 2008 | A1 |
| 20080306368 | Goode, Jr. et al. | Dec 2008 | A1 |
| 20080306434 | Dobbles et al. | Dec 2008 | A1 |
| 20080306435 | Kamath et al. | Dec 2008 | A1 |
| 20080306444 | Brister et al. | Dec 2008 | A1 |
| 20080319085 | Wright et al. | Dec 2008 | A1 |
| 20090005659 | Kollias et al. | Jan 2009 | A1 |
| 20090005666 | Shin et al. | Jan 2009 | A1 |
| 20090005729 | Hendrixson et al. | Jan 2009 | A1 |
| 20090006061 | Thukral et al. | Jan 2009 | A1 |
| 20090012376 | Agus | Jan 2009 | A1 |
| 20090012377 | Jennewine et al. | Jan 2009 | A1 |
| 20090012379 | Goode, Jr. et al. | Jan 2009 | A1 |
| 20090018424 | Kamath et al. | Jan 2009 | A1 |
| 20090018425 | Ouyang et al. | Jan 2009 | A1 |
| 20090030293 | Cooper et al. | Jan 2009 | A1 |
| 20090030294 | Petisce et al. | Jan 2009 | A1 |
| 20090036758 | Brauker et al. | Feb 2009 | A1 |
| 20090036763 | Brauker et al. | Feb 2009 | A1 |
| 20090036915 | Karbowniczek et al. | Feb 2009 | A1 |
| 20090040022 | Finkenzeller | Feb 2009 | A1 |
| 20090043181 | Brauker et al. | Feb 2009 | A1 |
| 20090043182 | Brauker et al. | Feb 2009 | A1 |
| 20090043525 | Brauker et al. | Feb 2009 | A1 |
| 20090043541 | Brauker et al. | Feb 2009 | A1 |
| 20090043542 | Brauker et al. | Feb 2009 | A1 |
| 20090045055 | Rhodes et al. | Feb 2009 | A1 |
| 20090048503 | Dalal et al. | Feb 2009 | A1 |
| 20090048563 | Ethelfeld et al. | Feb 2009 | A1 |
| 20090054745 | Jennewine et al. | Feb 2009 | A1 |
| 20090054747 | Fennell | Feb 2009 | A1 |
| 20090054748 | Feldman et al. | Feb 2009 | A1 |
| 20090054753 | Robinson et al. | Feb 2009 | A1 |
| 20090054866 | Teisen-Simony et al. | Feb 2009 | A1 |
| 20090062633 | Brauker et al. | Mar 2009 | A1 |
| 20090062635 | Brauker et al. | Mar 2009 | A1 |
| 20090069658 | Say et al. | Mar 2009 | A1 |
| 20090069750 | Schraga | Mar 2009 | A1 |
| 20090076356 | Simpson et al. | Mar 2009 | A1 |
| 20090076359 | Peyser | Mar 2009 | A1 |
| 20090076360 | Brister et al. | Mar 2009 | A1 |
| 20090076361 | Kamath et al. | Mar 2009 | A1 |
| 20090082693 | Stafford | Mar 2009 | A1 |
| 20090085873 | Betts et al. | Apr 2009 | A1 |
| 20090088614 | Taub | Apr 2009 | A1 |
| 20090088787 | Koike et al. | Apr 2009 | A1 |
| 20090093687 | Telfort et al. | Apr 2009 | A1 |
| 20090099436 | Brister et al. | Apr 2009 | A1 |
| 20090102678 | Mazza et al. | Apr 2009 | A1 |
| 20090105568 | Bugler | Apr 2009 | A1 |
| 20090105569 | Stafford | Apr 2009 | A1 |
| 20090105570 | Sloan et al. | Apr 2009 | A1 |
| 20090105571 | Fennell et al. | Apr 2009 | A1 |
| 20090124877 | Goode et al. | May 2009 | A1 |
| 20090124878 | Goode et al. | May 2009 | A1 |
| 20090124879 | Brister et al. | May 2009 | A1 |
| 20090124964 | Leach et al. | May 2009 | A1 |
| 20090124979 | Raymond et al. | May 2009 | A1 |
| 20090131768 | Simpson et al. | May 2009 | A1 |
| 20090131769 | Leach et al. | May 2009 | A1 |
| 20090131776 | Simpson et al. | May 2009 | A1 |
| 20090131777 | Simpson et al. | May 2009 | A1 |
| 20090131860 | Nielsen | May 2009 | A1 |
| 20090137886 | Shariati et al. | May 2009 | A1 |
| 20090137887 | Shariati et al. | May 2009 | A1 |
| 20090143659 | Li et al. | Jun 2009 | A1 |
| 20090143660 | Brister et al. | Jun 2009 | A1 |
| 20090156919 | Brister et al. | Jun 2009 | A1 |
| 20090156924 | Shariati et al. | Jun 2009 | A1 |
| 20090163790 | Brister et al. | Jun 2009 | A1 |
| 20090163791 | Brister et al. | Jun 2009 | A1 |
| 20090163855 | Shin et al. | Jun 2009 | A1 |
| 20090171182 | Stafford | Jul 2009 | A1 |
| 20090177068 | Stivoric et al. | Jul 2009 | A1 |
| 20090178459 | Li et al. | Jul 2009 | A1 |
| 20090182217 | Li et al. | Jul 2009 | A1 |
| 20090192366 | Mensinger et al. | Jul 2009 | A1 |
| 20090192380 | Shariati et al. | Jul 2009 | A1 |
| 20090192722 | Shariati et al. | Jul 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090192745 | Kamath et al. | Jul 2009 | A1 |
| 20090192751 | Kamath et al. | Jul 2009 | A1 |
| 20090198215 | Chong et al. | Aug 2009 | A1 |
| 20090203981 | Brauker et al. | Aug 2009 | A1 |
| 20090204341 | Brauker et al. | Aug 2009 | A1 |
| 20090212766 | Olson et al. | Aug 2009 | A1 |
| 20090216100 | Ebner et al. | Aug 2009 | A1 |
| 20090216103 | Brister et al. | Aug 2009 | A1 |
| 20090240120 | Mensinger et al. | Sep 2009 | A1 |
| 20090240128 | Mensinger et al. | Sep 2009 | A1 |
| 20090240193 | Mensinger et al. | Sep 2009 | A1 |
| 20090242399 | Kamath et al. | Oct 2009 | A1 |
| 20090242425 | Kamath et al. | Oct 2009 | A1 |
| 20090247855 | Boock et al. | Oct 2009 | A1 |
| 20090247856 | Boock et al. | Oct 2009 | A1 |
| 20090247857 | Harper et al. | Oct 2009 | A1 |
| 20090247931 | Damgaard-Sorensen | Oct 2009 | A1 |
| 20090259118 | Feldman et al. | Oct 2009 | A1 |
| 20090259201 | Hwang et al. | Oct 2009 | A1 |
| 20090259202 | Leeflang et al. | Oct 2009 | A1 |
| 20090270765 | Ghesquire et al. | Oct 2009 | A1 |
| 20090281406 | McGarraugh et al. | Nov 2009 | A1 |
| 20090287073 | Boock et al. | Nov 2009 | A1 |
| 20090287074 | Shults et al. | Nov 2009 | A1 |
| 20090292184 | Funderburk et al. | Nov 2009 | A1 |
| 20090292185 | Funderburk et al. | Nov 2009 | A1 |
| 20090294277 | Thomas et al. | Dec 2009 | A1 |
| 20090298182 | Schulat et al. | Dec 2009 | A1 |
| 20090299155 | Yang et al. | Dec 2009 | A1 |
| 20090299156 | Simpson et al. | Dec 2009 | A1 |
| 20090299162 | Brauker et al. | Dec 2009 | A1 |
| 20090299167 | Seymour | Dec 2009 | A1 |
| 20090299276 | Brauker et al. | Dec 2009 | A1 |
| 20100004597 | Gryn et al. | Jan 2010 | A1 |
| 20100010324 | Brauker et al. | Jan 2010 | A1 |
| 20100010329 | Taub et al. | Jan 2010 | A1 |
| 20100010331 | Brauker et al. | Jan 2010 | A1 |
| 20100010332 | Brauker et al. | Jan 2010 | A1 |
| 20100016687 | Brauker et al. | Jan 2010 | A1 |
| 20100016698 | Rasdal et al. | Jan 2010 | A1 |
| 20100022855 | Brauker et al. | Jan 2010 | A1 |
| 20100022863 | Mogensen et al. | Jan 2010 | A1 |
| 20100022988 | Wochner et al. | Jan 2010 | A1 |
| 20100030038 | Brauker et al. | Feb 2010 | A1 |
| 20100030053 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100030484 | Brauker et al. | Feb 2010 | A1 |
| 20100030485 | Brauker et al. | Feb 2010 | A1 |
| 20100036215 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036216 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036222 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036223 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036225 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036281 | Doi | Feb 2010 | A1 |
| 20100041971 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100045465 | Brauker et al. | Feb 2010 | A1 |
| 20100049014 | Funderburk et al. | Feb 2010 | A1 |
| 20100049024 | Saint et al. | Feb 2010 | A1 |
| 20100063373 | Kamath et al. | Mar 2010 | A1 |
| 20100069728 | Funderburk et al. | Mar 2010 | A1 |
| 20100076283 | Simpson et al. | Mar 2010 | A1 |
| 20100081908 | Dobbles et al. | Apr 2010 | A1 |
| 20100081910 | Brister et al. | Apr 2010 | A1 |
| 20100081953 | Syeda-Mahmood et al. | Apr 2010 | A1 |
| 20100087724 | Brauker et al. | Apr 2010 | A1 |
| 20100094251 | Estes et al. | Apr 2010 | A1 |
| 20100096259 | Zhang et al. | Apr 2010 | A1 |
| 20100099970 | Shults et al. | Apr 2010 | A1 |
| 20100099971 | Shults et al. | Apr 2010 | A1 |
| 20100100113 | Iio et al. | Apr 2010 | A1 |
| 20100105999 | Dixon et al. | Apr 2010 | A1 |
| 20100106088 | Yodfat et al. | Apr 2010 | A1 |
| 20100113897 | Brenneman et al. | May 2010 | A1 |
| 20100119693 | Tapsak et al. | May 2010 | A1 |
| 20100121167 | McGarraugh et al. | May 2010 | A1 |
| 20100121169 | Petisce et al. | May 2010 | A1 |
| 20100141656 | Krieftewirth | Jun 2010 | A1 |
| 20100152554 | Steine et al. | Jun 2010 | A1 |
| 20100160759 | Celentano et al. | Jun 2010 | A1 |
| 20100168538 | Keenan et al. | Jul 2010 | A1 |
| 20100168677 | Gabriel et al. | Jul 2010 | A1 |
| 20100174157 | Brister et al. | Jul 2010 | A1 |
| 20100174158 | Kamath et al. | Jul 2010 | A1 |
| 20100174163 | Brister et al. | Jul 2010 | A1 |
| 20100174164 | Brister et al. | Jul 2010 | A1 |
| 20100174165 | Brister et al. | Jul 2010 | A1 |
| 20100174166 | Brister et al. | Jul 2010 | A1 |
| 20100174167 | Kamath et al. | Jul 2010 | A1 |
| 20100174168 | Goode et al. | Jul 2010 | A1 |
| 20100174266 | Estes | Jul 2010 | A1 |
| 20100179401 | Rasdal et al. | Jul 2010 | A1 |
| 20100179402 | Goode et al. | Jul 2010 | A1 |
| 20100179404 | Kamath et al. | Jul 2010 | A1 |
| 20100179408 | Kamath et al. | Jul 2010 | A1 |
| 20100179409 | Kamath et al. | Jul 2010 | A1 |
| 20100185065 | Goode et al. | Jul 2010 | A1 |
| 20100185069 | Brister et al. | Jul 2010 | A1 |
| 20100185070 | Brister et al. | Jul 2010 | A1 |
| 20100185071 | Simpson et al. | Jul 2010 | A1 |
| 20100185072 | Goode et al. | Jul 2010 | A1 |
| 20100185075 | Brister et al. | Jul 2010 | A1 |
| 20100185175 | Kamen et al. | Jul 2010 | A1 |
| 20100191082 | Brister et al. | Jul 2010 | A1 |
| 20100198033 | Krulevitch et al. | Aug 2010 | A1 |
| 20100198034 | Thomas et al. | Aug 2010 | A1 |
| 20100198035 | Kamath et al. | Aug 2010 | A1 |
| 20100198036 | Kamath et al. | Aug 2010 | A1 |
| 20100198142 | Sloan et al. | Aug 2010 | A1 |
| 20100204557 | Kiaie et al. | Aug 2010 | A1 |
| 20100204653 | Gryn et al. | Aug 2010 | A1 |
| 20100212583 | Brister et al. | Aug 2010 | A1 |
| 20100213057 | Feldman et al. | Aug 2010 | A1 |
| 20100213080 | Celentano et al. | Aug 2010 | A1 |
| 20100214104 | Goode et al. | Aug 2010 | A1 |
| 20100217105 | Yodfat et al. | Aug 2010 | A1 |
| 20100217557 | Kamath et al. | Aug 2010 | A1 |
| 20100223013 | Kamath et al. | Sep 2010 | A1 |
| 20100223022 | Kamath et al. | Sep 2010 | A1 |
| 20100223023 | Kamath et al. | Sep 2010 | A1 |
| 20100228109 | Kamath et al. | Sep 2010 | A1 |
| 20100228497 | Kamath et al. | Sep 2010 | A1 |
| 20100240975 | Goode et al. | Sep 2010 | A1 |
| 20100240976 | Goode et al. | Sep 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100262201 | He et al. | Oct 2010 | A1 |
| 20100274107 | Boock et al. | Oct 2010 | A1 |
| 20100274111 | Say et al. | Oct 2010 | A1 |
| 20100275108 | Sloan et al. | Oct 2010 | A1 |
| 20100280341 | Boock et al. | Nov 2010 | A1 |
| 20100286496 | Simpson et al. | Nov 2010 | A1 |
| 20100298684 | Leach et al. | Nov 2010 | A1 |
| 20100313105 | Nekoomaram et al. | Dec 2010 | A1 |
| 20100317952 | Budiman et al. | Dec 2010 | A1 |
| 20100324392 | Yee et al. | Dec 2010 | A1 |
| 20100324403 | Brister et al. | Dec 2010 | A1 |
| 20100326842 | Mazza et al. | Dec 2010 | A1 |
| 20100331642 | Bruce et al. | Dec 2010 | A1 |
| 20100331644 | Neale et al. | Dec 2010 | A1 |
| 20100331647 | Shah et al. | Dec 2010 | A1 |
| 20100331648 | Kamath et al. | Dec 2010 | A1 |
| 20100331653 | Stafford | Dec 2010 | A1 |
| 20100331656 | Mensinger et al. | Dec 2010 | A1 |
| 20100331657 | Mensinger et al. | Dec 2010 | A1 |
| 20110004085 | Mensinger et al. | Jan 2011 | A1 |
| 20110009727 | Mensinger et al. | Jan 2011 | A1 |
| 20110021889 | Hoss et al. | Jan 2011 | A1 |
| 20110024043 | Boock et al. | Feb 2011 | A1 |
| 20110024307 | Simpson et al. | Feb 2011 | A1 |
| 20110027127 | Simpson et al. | Feb 2011 | A1 |
| 20110027453 | Boock et al. | Feb 2011 | A1 |
| 20110027458 | Boock et al. | Feb 2011 | A1 |
| 20110028815 | Simpson et al. | Feb 2011 | A1 |
| 20110028816 | Simpson et al. | Feb 2011 | A1 |
| 20110031986 | Bhat et al. | Feb 2011 | A1 |
| 20110040163 | Telson et al. | Feb 2011 | A1 |
| 20110040256 | Bobroff et al. | Feb 2011 | A1 |
| 20110040263 | Hordum et al. | Feb 2011 | A1 |
| 20110046456 | Hordum et al. | Feb 2011 | A1 |
| 20110046467 | Simpson et al. | Feb 2011 | A1 |
| 20110054275 | Stafford | Mar 2011 | A1 |
| 20110054282 | Nekoomaram et al. | Mar 2011 | A1 |
| 20110060196 | Stafford | Mar 2011 | A1 |
| 20110060530 | Fennell | Mar 2011 | A1 |
| 20110073475 | Kastanos et al. | Mar 2011 | A1 |
| 20110077490 | Simpson et al. | Mar 2011 | A1 |
| 20110077494 | Doniger et al. | Mar 2011 | A1 |
| 20110081726 | Berman et al. | Apr 2011 | A1 |
| 20110082484 | Saravia et al. | Apr 2011 | A1 |
| 20110106126 | Love et al. | May 2011 | A1 |
| 20110112696 | Yodfat et al. | May 2011 | A1 |
| 20110118579 | Goode et al. | May 2011 | A1 |
| 20110118580 | Goode et al. | May 2011 | A1 |
| 20110124992 | Brauker et al. | May 2011 | A1 |
| 20110124997 | Goode et al. | May 2011 | A1 |
| 20110125410 | Goode et al. | May 2011 | A1 |
| 20110130970 | Goode et al. | Jun 2011 | A1 |
| 20110130971 | Goode et al. | Jun 2011 | A1 |
| 20110130998 | Goode et al. | Jun 2011 | A1 |
| 20110137257 | Gyrn et al. | Jun 2011 | A1 |
| 20110144465 | Shults et al. | Jun 2011 | A1 |
| 20110148905 | Simmons et al. | Jun 2011 | A1 |
| 20110178378 | Brister et al. | Jul 2011 | A1 |
| 20110178461 | Chong et al. | Jul 2011 | A1 |
| 20110184258 | Stafford | Jul 2011 | A1 |
| 20110190603 | Stafford | Aug 2011 | A1 |
| 20110190614 | Brister et al. | Aug 2011 | A1 |
| 20110191044 | Stafford | Aug 2011 | A1 |
| 20110201910 | Rasdal et al. | Aug 2011 | A1 |
| 20110201911 | Johnson et al. | Aug 2011 | A1 |
| 20110208027 | Wagner et al. | Aug 2011 | A1 |
| 20110213225 | Bernstein et al. | Sep 2011 | A1 |
| 20110218414 | Kamath et al. | Sep 2011 | A1 |
| 20110231107 | Brauker et al. | Sep 2011 | A1 |
| 20110231140 | Goode et al. | Sep 2011 | A1 |
| 20110231141 | Goode et al. | Sep 2011 | A1 |
| 20110231142 | Goode et al. | Sep 2011 | A1 |
| 20110253533 | Shults et al. | Oct 2011 | A1 |
| 20110257495 | Hoss et al. | Oct 2011 | A1 |
| 20110257521 | Fraden | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20110263958 | Brauker et al. | Oct 2011 | A1 |
| 20110270062 | Goode et al. | Nov 2011 | A1 |
| 20110270158 | Brauker et al. | Nov 2011 | A1 |
| 20110275919 | Petisce et al. | Nov 2011 | A1 |
| 20110282327 | Kellogg et al. | Nov 2011 | A1 |
| 20110287528 | Fern et al. | Nov 2011 | A1 |
| 20110288574 | Curry et al. | Nov 2011 | A1 |
| 20110289497 | Kiaie et al. | Nov 2011 | A1 |
| 20110290645 | Brister et al. | Dec 2011 | A1 |
| 20110313543 | Brauker et al. | Dec 2011 | A1 |
| 20110319729 | Donnay et al. | Dec 2011 | A1 |
| 20110319733 | Stafford | Dec 2011 | A1 |
| 20110319738 | Woodruff et al. | Dec 2011 | A1 |
| 20110319739 | Kamath et al. | Dec 2011 | A1 |
| 20110320130 | Valdes et al. | Dec 2011 | A1 |
| 20120010642 | Lee et al. | Jan 2012 | A1 |
| 20120035445 | Boock et al. | Feb 2012 | A1 |
| 20120040101 | Tapsak et al. | Feb 2012 | A1 |
| 20120046534 | Simpson et al. | Feb 2012 | A1 |
| 20120078071 | Bohm et al. | Mar 2012 | A1 |
| 20120088995 | Fennell et al. | Apr 2012 | A1 |
| 20120108934 | Valdes et al. | May 2012 | A1 |
| 20120108983 | Banet et al. | May 2012 | A1 |
| 20120123385 | Edwards et al. | May 2012 | A1 |
| 20120165626 | Irina et al. | Jun 2012 | A1 |
| 20120165640 | Galley et al. | Jun 2012 | A1 |
| 20120173200 | Breton et al. | Jul 2012 | A1 |
| 20120184909 | Gyrn et al. | Jul 2012 | A1 |
| 20120190989 | Kaiser et al. | Jul 2012 | A1 |
| 20120245447 | Karan et al. | Sep 2012 | A1 |
| 20120296327 | Hutchins et al. | Nov 2012 | A1 |
| 20130035575 | Mayou et al. | Feb 2013 | A1 |
| 20130047981 | Bacon | Feb 2013 | A1 |
| 20130109940 | Yang et al. | May 2013 | A1 |
| 20130184547 | Taub et al. | Jul 2013 | A1 |
| 20130225959 | Bugler | Aug 2013 | A1 |
| 20130235166 | Jones et al. | Sep 2013 | A1 |
| 20130253289 | Hadvary et al. | Sep 2013 | A1 |
| 20140121480 | Budiman et al. | May 2014 | A1 |
| 20140148667 | Boock et al. | May 2014 | A1 |
| 20150105644 | Yang et al. | Apr 2015 | A1 |
| 20150241407 | Ou et al. | Aug 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 4401400 | Jul 1995 | DE |
| 0098592 | Jan 1984 | EP |
| 0127958 | Dec 1984 | EP |
| 0320109 | Jun 1989 | EP |
| 0353328 | Feb 1990 | EP |
| 0390390 | Oct 1990 | EP |
| 0396788 | Nov 1990 | EP |
| 0286118 | Jan 1995 | EP |
| 1048264 | Nov 2000 | EP |
| 1177802 | Feb 2002 | EP |
| 0987982 | Jan 2007 | EP |
| 2060284 | May 2009 | EP |
| 2201969 | Jun 2010 | EP |
| 2327362 | Jun 2011 | EP |
| 2335587 | Jun 2011 | EP |
| 11-506629 | Jun 1999 | JP |
| 2003-527138 | Sep 2003 | JP |
| 2004-520103 | Jul 2004 | JP |
| 2004-520898 | Jul 2004 | JP |
| 2006-517804 | Aug 2006 | JP |
| WO-1996039977 | May 1996 | WO |
| WO-1996025089 | Aug 1996 | WO |
| WO-1996035370 | Nov 1996 | WO |
| WO-1997021457 | Jun 1997 | WO |
| WO-1998035053 | Aug 1998 | WO |
| WO-1998056293 | Dec 1998 | WO |
| WO-1999033504 | Jul 1999 | WO |
| WO-1999056613 | Nov 1999 | WO |
| WO-2000049940 | Aug 2000 | WO |
| WO-2000059370 | Oct 2000 | WO |
| WO-2000078992 | Dec 2000 | WO |
| WO-2001052935 | Jul 2001 | WO |
| WO-2001054753 | Aug 2001 | WO |
| WO-2002016905 | Feb 2002 | WO |
| WO-2002050534 | Jun 2002 | WO |
| WO-2002058537 | Aug 2002 | WO |
| WO-2003028784 | Apr 2003 | WO |
| WO-2003073936 | Sep 2003 | WO |
| WO-2003076893 | Sep 2003 | WO |
| WO-2003082091 | Oct 2003 | WO |
| WO-2003085372 | Oct 2003 | WO |
| WO-2004030726 | Apr 2004 | WO |
| WO-2004054445 | Jul 2004 | WO |
| WO-2004060436 | Jul 2004 | WO |
| WO-2004061420 | Jul 2004 | WO |
| WO-2004098684 | Nov 2004 | WO |
| WO-2004098685 | Nov 2004 | WO |
| WO-2004107971 | Dec 2004 | WO |
| WO-2004112602 | Dec 2004 | WO |
| WO-2005037184 | Apr 2005 | WO |
| WO-2005084534 | Sep 2005 | WO |
| WO-2005089103 | Sep 2005 | WO |
| WO-2005092177 | Oct 2005 | WO |
| WO-2006001024 | Jan 2006 | WO |
| WO-2006015922 | Feb 2006 | WO |
| WO-2006024671 | Mar 2006 | WO |
| WO-2006042811 | Apr 2006 | WO |
| WO-2006061354 | Jun 2006 | WO |
| WO-2006108809 | Oct 2006 | WO |
| WO-2007097754 | Aug 2007 | WO |
| WO-2007140783 | Dec 2007 | WO |
| WO-2008065646 | Jun 2008 | WO |
| WO-2008133702 | Nov 2008 | WO |
| WO-2009062675 | May 2009 | WO |
| WO-2010112521 | Oct 2010 | WO |
| WO-2011002815 | Jan 2011 | WO |
| Entry |
|---|
| Alcock, S. J., et al., “Continuous Analyte Monitoring to Aid Clinical Practice”, IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325. |
| Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526. |
| Aussedat, B., et al., “A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycemic Alarm”, Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071. |
| Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33. |
| Bindra, D. S., et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring”, Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696. |
| Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10. |
| Bobbioni-Harsch, E., et al., “Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats”, Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463. |
| Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56. |
| Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671. |
| Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2. Superiority of the One-Point Calibration Method”, Biosensors and Bioelectronics, vol. 17, No. 8, 2002, pp. 647-654. |
| Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current”, Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646. |
| Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244. |
| Dexcom, “STS User's Guide”, DexCom, Inc., 2006, pp. 1-111. |
| Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779. |
| Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004. |
| Gregg, B. A., et al., “Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Bionsensor Applications”, Analytical Chemistry, vol. 62, No. 3, 1990, pp. 258-263. |
| Guerci, B., et al., “Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs”, Diabetes Care vol. 26, 2003, pp. 582-589. |
| Gunasingham, et al., “Electrochemically Modulated Optrode for Glucose”, Biosensors & Bioelectronics, vol. 7, 1992, pp. 353-359. |
| Harrison, D. J., et al., “Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniatureized Integrated Potentiostat for Glucose Analysis in Whole Blood”, Analytical Chemistry, vol. 60, No. 19, 1988, pp. 2002-2007. |
| Heller, A., “Electrical Connection Enzyme Redox Centers to Electrodes”, Journal of Physical Chemistry, vol. 96, No. 9, 1990, pp. 3579-3587. |
| Ikeda, T., et al., “Artificial Pancreas—Investigation of the Stability of Glucose Sensors Using a Telemetry System” (English language translation of abstract), Jpn. J. Artif. Organs, vol. 19, No. 2, 1990, pp. 889-892. |
| Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652. |
| Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719. |
| Johnson, K. W., et al., “In vivo Evaluation of an Electroenzymatic Glucose Sensor Implanted in Subcutaneous Tissue”, Biosensors & Bioelectronics, vol. 7, 1992, pp. 709-714. |
| Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198. |
| Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250. |
| Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304. |
| Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549. |
| Kovatchev, B. P., et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, 2004, pp. 1922-1928. |
| Lortz, J., et al., “What is Bluetooth? We Explain The Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74. |
| Maidan, R., et al., “Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors”, Analytical Chemistry, vol. 64, No. 23, 1992, pp. 2889-2896. |
| Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658. |
| Mastrototaro, J. J., et al., “An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate”, Sensors and Actuators B, vol. 5, 1991, pp. 139-144. |
| Mauras, N., et al., “Lack of Accuracy of Continuous Glucose Sensors in Healthy, Nondiabetic Children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy Study,” Journal of Pediatrics, 2004, pp. 770-775. |
| McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense Inc., 2001, 16 Pages. |
| McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376. |
| McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532. |
| Minimed Technologies, “Tape Tips and Other Infusion Site Information”, 1995. |
| Moatti-Sirat, D., et al., “Towards Continuous Glucose Monitoring: In Vivo Evaluation of a Miniaturized Glucose Sensor Implanted for Several Days in Rat Subcutaneous Tissue”, Diabetologia, vol. 35, 1992, pp. 224-330. |
| Ohara, T. J., et al., “Glucose Electrodes Based on Cross-Linked [Os(bpy)2Cl]+/2+ Complexed Poly(1-Vinylimidazole) Films”, Analytical Chemistry, vol. 65, No. 23, 1993, pp. 3512-3517. |
| Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346. |
| Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217. |
| Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272. |
| Poitout, V., et al., “In Vitro and In Vivo Evaluation in Dogs of a Miniaturized Glucose Sensor”, ASAIO Transactions, vol. 37, No. 3, 1991, pp. M298-M300. |
| Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161. |
| Reach, G., et al., “Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?”, Analytical Chemistry, vol. 64, No. 6, 1992, pp. 381-386. |
| Rebrin, K., et al., “Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs”, Diabetologia, vol. 32, 1989, pp. 573-576. |
| Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241. |
| Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158. |
| Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322. |
| Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308. |
| Schmidt, F. J., et al., “Calibration of a Wearable Glucose Sensor”, The International Journal of Artificial Organs, vol. 15, No. 1, 1992, pp. 55-61. |
| Schmidtke, D. W., et al., “Accuracy of the One-Point In Vivo Calibration of ‘Wired’ Glucose Oxidase Electrodes Implanted in Jugular Veins of Rats in Periods of Rapid Rise and Decline of the Glucose Concentration”, Analytical Chemistry, vol. 70, No. 10, 1998, pp. 2149-2155. |
| Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299. |
| Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406. |
| Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184. |
| Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20. |
| Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313. |
| Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210. |
| Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301. |
| Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131. |
| Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942. |
| Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40. |
| Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261. |
| Tierney, M. J., et al., “Effect of Acetaminophen on the Accuracy of Glucose Measurements Obtained with the GlucoWatch Biographer”, Diabetes Technology & Therapeutics, vol. 2, No. 2, 2000, pp. 199-207. |
| Tsalikian, E., et al., “Accuracy of the GlucoWatch G2® Biographer and the Continuous Glucose Monitoring System During Hypoglycemia: Experience of the Diabetes Research in Children Network”, Diabetes Care, vol. 27, No. 3, 2004, pp. 722-726. |
| Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors vol. 1, 1985, pp. 85-115. |
| Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137. |
| Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964. |
| Ward, W. K., et al., “Rise in Background Current Over Time in a Subcutaneous Glucose Sensor in the Rabbit: Relevance to Calibration and Accuracy”, Biosensors & Bioelectronics, vol. 15, 2000, pp. 53-61. |
| Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617. |
| Ye, L., et al., “High Current Density ‘Wired’ Quinoprotein Glucose Dehydrogenase Electrode”, Analytical Chemistry, vol. 65, No. 3, 1993, pp. 238-241. |
| Canadian Patent Application No. 2872576, Examiner's Report dated Feb. 17, 2015. |
| Canadian Patent Application No. 2872576, Examiner's Report dated Feb. 19, 2016. |
| European Patent Application No. 15002441.2, Extended European Search Report dated Dec. 18, 2015. |
| European Patent Application No. EP-06851063.5, Extended European Search Report dated Sep. 21, 2009. |
| European Patent Application No. EP-07843396.8, Extended European Search Report dated Dec. 22, 2010. |
| European Patent Application No. EP-07843396.8, Intention to Grant a European Patent dated Sep. 17, 2012. |
| European Patent Application No. EP-13000104.3, Extended European Search Report dated Mar. 12, 2013. |
| European Patent Application No. EP-14179905.6, Notice of Opposition filed May 19, 2016. |
| PCT Application No. PCT/US2006/062690, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Jul. 10, 2008. |
| PCT Application No. PCT/US2006/062690, International Search Report and Written Opinion of the International Searching Authority dated Jan. 2, 2008. |
| PCT Application No. PCT/US2007/079774, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 9, 2009. |
| PCT Application No. PCT/US2007/079774, International Search Report and Written Opinion of the International Searching Authority dated Mar. 13, 2008. |
| U.S. Appl. No. 11/535,983, Notice of Allowance dated Feb. 19, 2010. |
| U.S. Appl. No. 11/535,983, Office Action dated Jun. 26, 2009. |
| U.S. Appl. No. 11/535,983, Office Action dated Oct. 3, 2008. |
| U.S. Appl. No. 11/617,698, Notice of Allowance dated May 24, 2013. |
| U.S. Appl. No. 11/617,698, Office Action dated Dec. 17, 2009. |
| U.S. Appl. No. 11/617,698, Office Action dated Jun. 21, 2010. |
| U.S. Appl. No. 11/617,698, Office Action dated Jun. 26, 2009. |
| U.S. Appl. No. 11/617,698, Office Action dated Nov. 29, 2010. |
| U.S. Appl. No. 11/617,698, Office Action dated Oct. 2, 2012. |
| U.S. Appl. No. 11/617,698, Office Action dated Oct. 3, 2008. |
| U.S. Appl. No. 12/571,349, Notice of Allowance dated Aug. 18, 2014. |
| U.S. Appl. No. 12/571,349, Office Action dated Apr. 29, 2011. |
| U.S. Appl. No. 12/571,349, Office Action dated Mar. 14, 2014. |
| U.S. Appl. No. 12/571,349, Office Action dated Nov. 10, 2010. |
| U.S. Appl. No. 12/571,349, Office Action dated Oct. 11, 2013. |
| U.S. Appl. No. 14/500,705, Interview Summary dated Dec. 18, 2015. |
| U.S. Appl. No. 14/500,705, Notice of Allowance dated Feb. 24, 2016. |
| U.S. Appl. No. 14/500,705, Notice of Allowance dated Jan. 20, 2016. |
| U.S. Appl. No. 14/500,705, Office Action dated May 7, 2015. |
| U.S. Appl. No. 14/500,705, Office Action dated Nov. 5, 2015. |
| U.S. Appl. No. 15/141,819, Advisory Action dated Aug. 28, 2017. |
| U.S. Appl. No. 15/141,819, Notice of Allowance dated Sep. 7, 2017. |
| U.S. Appl. No. 15/141,819, Office Action dated Jul. 28, 2016. |
| U.S. Appl. No. 15/141,819, Office Action dated Jun. 1, 2017. |
| U.S. Appl. No. 15/473,560, Office Action dated Dec. 12, 2017. |
| U.S. Appl. No. 15/789,946, Notice of Allowance dated Jan. 18, 2019. |
| U.S. Appl. No. 15/789,946, Office Action dated Apr. 6, 2018. |
| U.S. Appl. No. 15/789,946, Office Action dated Nov. 1, 2018. |
| U.S. Appl. No. 14/040,674, Office Action dated Oct. 21, 2016. |
| U.S. Patent Reexamination Application No. 90/008,172, Request for Reexamination of U.S. Pat. No. 6,990,366, filed Aug. 16, 2006. |
| U.S. Patent Reexamination Application No. 90/008,457, Notice of Intent to Issue Reexamination Certificate dated Mar. 13, 2008. |
| U.S. Patent Reexamination Application No. 90/008,457, Order Granting Request for Reexamination dated Feb. 23, 2007. |
| U.S. Patent Reexamination Application No. 90/008,457, Request for Reexamination of U.S. Pat. No. 6,990,366, filed Jan. 23, 2007. |
| U.S. Patent Reexamination Application No. 90/009,328 & 90/009,328, Notice of Intent to Issue Reexamination Certificate dated Nov. 20, 2009. |
| U.S. Patent Reexamination Application No. 90/009,328 & 90/009,328, Office Action dated Aug. 4, 2009. |
| U.S. Patent Reexamination Application No. 90/009,328 & 90/009,328, Office Action dated Sep. 30, 2009. |
| U.S. Patent Reexamination Application No. 90/009,104, Office Action dated Oct. 16, 2008. |
| U.S. Patent Reexamination Application No. 90/009,104, Order Granting Request for Reexamination dated Jun. 5, 2008. |
| U.S. Patent Reexamination Application No. 90/009,104, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Apr. 8, 2008. |
| U.S. Patent Reexamination Application No. 90/009,328, Order Granting Request for Reexamination dated Dec. 9, 2008. |
| U.S. Patent Reexamination Application No. 90/009,328, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Nov. 10, 2008. |
| U.S. Patent Reexamination Application No. 90/010,791, Notice of Intent to Issue Reexamination Certificate dated May 17, 2011. |
| U.S. Patent Reexamination Application No. 90/010,791, Office Action dated Dec. 17, 2010. |
| U.S. Patent Reexamination Application No. 90/010,791, Office Action dated May 28, 2010. |
| U.S. Patent Reexamination Application No. 90/010,791, Order Granting Request for Reexamination dated Feb. 22, 2010. |
| U.S. Patent Reexamination Application No. 90/010,791, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Dec. 22, 2009. |
| U.S. Patent Reexamination Application No. 90/011,730, Notice of Intent to Issue Reexam Certificate for U.S. Pat. No. 6,990,366 dated Apr. 5, 2012. |
| U.S. Patent Reexamination Application No. 90/011,730, Office Action dated Jan. 11, 2012. |
| U.S. Patent Reexamination Application No. 90/011,730, Order Granting Request for Reexamination of U.S. Pat. No. 6,990,366 dated Aug. 24, 2011. |
| U.S. Patent Reexamination Application No. 90/011,730, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Jun. 3, 2011. |
| U.S. Patent Reexamination Application No. 95/002,113, Order Denying Request for Reexamination of U.S. Pat. No. 6,990,366 dated Nov. 13, 2012. |
| U.S. Patent Reexamination Application No. 95/002,113, Petition for Review of the Order Denying Request Reexamination of U.S. Pat. No. 6,990,366 dated Dec. 13, 2012. |
| U.S. Patent Reexamination Application No. 95/002,113, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Aug. 30, 2012. |
| U.S. Patent Reexamination Application No. 95/002,162, Order Denying Request for Reexamination of U.S. Pat. No. 8,175,673 dated Nov. 13, 2012. |
| U.S. Patent Reexamination Application No. 95/002,162, Petition for Review of the Order Denying Request Reexamination of U.S. Pat. No. 8,175,673 dated Dec. 13, 2012. |
| U.S. Patent Reexamination Application No. 95/002,162, Request for Reexamination of U.S. Pat. No. 8,175,673 filed Sep. 7, 2012. |
| Number | Date | Country | |
|---|---|---|---|
| 20190282137 A1 | Sep 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60754870 | Dec 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15789946 | Oct 2017 | US |
| Child | 16429882 | US | |
| Parent | 15141819 | Apr 2016 | US |
| Child | 15789946 | US | |
| Parent | 14500705 | Sep 2014 | US |
| Child | 15141819 | US | |
| Parent | 12571349 | Sep 2009 | US |
| Child | 14500705 | US | |
| Parent | 11535983 | Sep 2006 | US |
| Child | 12571349 | US |
